<SEC-DOCUMENT>0001140361-26-015951.txt : 20260421
<SEC-HEADER>0001140361-26-015951.hdr.sgml : 20260421
<ACCEPTANCE-DATETIME>20260421171528
ACCESSION NUMBER:		0001140361-26-015951
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20260421
DATE AS OF CHANGE:		20260421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Momentus Inc.
		CENTRAL INDEX KEY:			0001781162
		STANDARD INDUSTRIAL CLASSIFICATION:	GUIDED MISSILES & SPACE VEHICLES & PARTS [3760]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				841905538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-295224
		FILM NUMBER:		26880550

	BUSINESS ADDRESS:	
		STREET 1:		1762 AUTOMATION PARKWAY
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131
		BUSINESS PHONE:		6505647820

	MAIL ADDRESS:	
		STREET 1:		1762 AUTOMATION PARKWAY
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stable Road Acquisition Corp.
		DATE OF NAME CHANGE:	20190628
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>ny20070923x1_s3.htm
<DESCRIPTION>S-3
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head><body style="color: #000000;" bgcolor="#ffffff">
<!--Begin Page 1-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 540pt;"><a name="ny20070923x1_s3_100-regcov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 540pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 25pt; text-align: center;">As filed with the Securities and Exchange Commission on April&#160;21, 2026. </div><div class="BRDSX_regno" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 1pt; text-align: right;">Registration No. 333-&#8195;&#8195;&#8195;</div></div></div><div class="BRDSX_block-frill" style="width: 540pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="BRDSX_block-main" style="width: 540pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 9.5pt; text-align: center;">UNITED STATES <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; text-align: center;">SECURITIES AND EXCHANGE COMMISSION<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt;">Washington, D.C. 20549 </font></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 6pt; text-align: center;">FORM S-3<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 11pt;"><font style="font-size: 11pt;">REGISTRATION STATEMENT</font><br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 11pt;"><font style="font-size: 11pt; font-style: italic;">UNDER</font><br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 11pt;"><font style="font-size: 11pt; font-style: italic;">THE SECURITIES ACT OF 1933</font><font style="font-size: 11pt; font-weight: normal;"> </font></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 20pt; font-weight: bold; margin-top: 12pt; text-align: center;">MOMENTUS INC.<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 10pt;"><font style="font-size: 10pt;">(Exact Name of Registrant as Specified in Its Charter) </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -2pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 172pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Delaware</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">3714</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">84-1905538 </div></td></tr><tr><td style="width: 172pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(State or Other Jurisdiction of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Incorporation or Organization) </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Primary Standard Industrial <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Classification Code Number)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(I.R.S. Employer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Identification Number)</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;">1762 Automation Parkway <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">San Jose, CA 95131 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(650) 564-7820 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Address, Including Zip Code, and Telephone Number, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Including Area Code, of Registrant&#8217;s Principal Executive Offices)<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; text-align: center;">John C. Rood <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Chief Executive Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">1762 Automation Parkway <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">San Jose, CA 95131 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Telephone: (650) 564-7820 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service)<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8pt; text-align: center;">Copies to:<font style="font-style: normal; font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -2pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 264pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stephen C. Hinton, Esq. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Bradley Arant Boult Cummings LLP <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">ONE 22 ONE <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">1221 Broadway <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Nashville, Tennessee 37203 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Telephone: (615) 252-3585</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Lon Ensler <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Chief Financial Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">1762 Automation Parkway <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">San Jose, California 95131 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Telephone: (650) 564-7820</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;">Approximate date of commencement of proposed sale to the public: <font style="font-weight: normal;">From time to time after the effective date of this registration statement. </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. &#x2612; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If this Form&#160;is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box. &#8201;<font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If this Form&#160;is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -1pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -1pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 216pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Large accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.5pt; font-family: Arial, Helvetica, sans-serif;">&#x2610;</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.5pt; font-family: Arial, Helvetica, sans-serif;">&#x2610;</font><font style="font-size: 9.5pt;"> </font></div></td></tr><tr><td style="width: 216pt; padding-top: 0.02pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.02pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#x2612;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; padding-top: 0.02pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Smaller reporting company</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.02pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#x2612; </div></td></tr><tr><td style="width: 216pt; padding-top: 0.02pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.02pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 264pt; padding-top: 0.02pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Emerging growth company</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.34pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.5pt; font-family: Arial, Helvetica, sans-serif;">&#x2610;</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. <font style="font-size: 1pt;">&#8201;</font><font style="font-family: Arial, Helvetica, sans-serif;">&#x2610;</font> </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.<font style="font-weight: normal;"> </font></div></div><div class="BRDSX_block-frill" style="width: 540pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 1-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20070923x1_s3_101-cov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #FC0014; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><div style="font-family: Arial, Helvetica, sans-serif; text-align: left; margin-bottom: 12pt;">The information in this prospectus is not complete and may be changed. The securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </div>Subject to Completion. Dated April 21, 2026<font style="color: #000000;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">PRELIMINARY PROSPECTUS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; text-align: center;"><img style="height: 123px; width: 134px;" src="logo_momentus3.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 16pt; font-weight: bold; margin-top: 17.5pt; text-align: center;">Momentus Inc. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">Up to 1,400,000 Shares of Common Stock </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify; line-height: 11.5pt;">This Prospectus relates to the offer and sale from time-to-time of up to 1,400,000 shares of Class A common stock, par value $0.00001 per share (the &#8220;Common Stock&#8221;), of Momentus Inc. (the &#8220;Company,&#8221; &#8220;Momentus,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;) by the Selling Stockholders identified in this prospectus or their permitted transferees (collectively, the &#8220;Selling Stockholders&#8221;). The shares of Common Stock registered for resale pursuant to this prospectus consist of (i) 450,000 shares of Common Stock (the &#8220;Private Placement Shares&#8221;) issued to the Selling Stockholders pursuant to the Securities Purchase Agreement dated April&#160;14, 2026 (the &#8220;April&#160;2026 SPA&#8221;); (ii) 883,334 shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;) issuable upon the exercise of certain pre-funded warrants issued to the Selling Stockholders on April 15, 2026 (the &#8220;Pre-Funded Warrants&#8221;); and (iii) 66,666 shares of Common Stock (the &#8220;PA Warrant Shares&#8221; and, together with the Private Placement Shares, and Pre-Funded Warrant Shares, the &#8220;Shares&#8221;) issuable upon exercise of certain warrants issued to the Selling Stockholders on April&#160;15, 2026 (the &#8220;PA Warrants&#8221; and, together with the Pre-Funded Warrants, the &#8220;Warrants&#8221;). </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify; line-height: 11.5pt;">We are not selling any shares of Common Stock under this prospectus and will not receive any proceeds from the sale by the Selling Stockholders of the Shares. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Sales of the Shares by the Selling Stockholders may occur at fixed prices, at market prices prevailing at the time of sale, at prices related to the prevailing market or at negotiated prices. The Selling Stockholders may sell shares to or through underwriters, broker-dealer or agents, who may receive compensation in the form of discounts, concessions or commissions from the Selling Stockholders, the purchasers of the shares, or both. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify; line-height: 11.5pt;">We will not receive any of the proceeds from such sales of the shares of Common Stock. We will bear all costs, expenses and fees in connection with the registration of these securities, including with regard to compliance with state securities or &#8220;blue sky&#8221; laws. The Selling Stockholders will bear all commissions and discounts, if any, attributable to its sale of shares of Common Stock. See &#8220;<font style="font-style: italic;">Plan of Distribution</font>&#8221; of this prospectus. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify; line-height: 11.5pt;">Our registration of the securities covered by this prospectus does not mean that either we or the Selling Stockholders will issue, offer or sell any of the Shares. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify; line-height: 11.5pt;">On Wednesday, December&#160;17, 2025, the Company effected a 1-for-17.85 reverse stock split. Unless otherwise noted, all share, per share and pricing information relating to our Common Stock in this registration statement is presented on a post-split basis. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify; line-height: 11.5pt;">Our Common Stock is listed on the Nasdaq Capital Market under the symbol &#8220;MNTS.&#8221; On April 17, 2026, the last reported sale price of our Common Stock was $7.50 per share. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify; line-height: 11.5pt;">We are a &#8220;smaller reporting company&#8221; as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and, as such, have elected to take advantage of certain of the scaled disclosures available for smaller reporting companies. See &#8220;<font style="font-style: italic;">Prospectus Summary &#8211; Implications of Being a Smaller Reporting Company</font>.&#8221; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify; line-height: 11.5pt;">Investing in our securities involves risks. See the section entitled &#8220;Risk Factors&#8221; on page <a href="#tRF">8</a> of this prospectus to read about factors you should consider before buying our securities. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 42.5pt; text-align: center;">The date of this prospectus is &#8195;&#8195;&#8195;, 2026.</div></div></div></div>
<!--End Page 2-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_102-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS </div><a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 432pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP">ABOUT THIS PROSPECTUS<font style="padding-left: 0.99pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tATP"><font style="padding-left: 4.44pt;">ii</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS<font style="padding-left: 3.52pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS"><font style="padding-left: 1.66pt;">iii</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPS">PROSPECTUS SUMMARY<font style="padding-left: 3.67pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPS"><font style="padding-left: 5pt;">1</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tOFF">THE OFFERING<font style="padding-left: 3.68pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tOFF"><font style="padding-left: 5pt;">7</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 0.15pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF"><font style="padding-left: 5pt;">8</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP">USE OF PROCEEDS<font style="padding-left: 1.73pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUOP"><font style="padding-left: 0.37pt;">11</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSS">SELLING STOCKHOLDER<font style="padding-left: 2.2pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSS">12 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">PLAN OF DISTRIBUTION<font style="padding-left: 0.64pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOD">14 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 4.05pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">16 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXP">EXPERTS<font style="padding-left: 1.77pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXP">16 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 2.99pt;"></font></a></div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">16</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tICI">INCORPORATION OF CERTAIN INFORMATION BY REFERENCE<font style="padding-left: 2.16pt;"></font></a></div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tICI">17</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 3-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_103-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tATP"><!--Anchor--></a>ABOUT THIS PROSPECTUS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">You should rely only on the information contained in this prospectus, as well as the information incorporated by reference into this prospectus and any applicable prospectus supplement. Neither we nor the Selling Stockholders have authorized anyone to provide you with different information. Neither we nor the Selling Stockholders are making an offer of these securities in any jurisdiction where the offer is not permitted. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The information contained in this prospectus and any prospectus supplement is accurate only as of the respective dates thereof, and the information in the documents incorporated by reference in this prospectus is accurate only as of the date of those respective documents, regardless of the time of delivery of this prospectus or of any sale of our securities. You should not assume that the information in this prospectus, any applicable prospectus supplement or any documents incorporated by reference is accurate as of any date other than the date of the applicable document. Since the date of this prospectus and the documents incorporated by reference in this prospectus, our business, financial condition, results of operations and prospects may have changed. You should read this prospectus and the related exhibits filed with the SEC, together with the additional information described under the headings &#8220;<font style="font-style: italic;">Where You Can Find More Information</font>&#8221; and &#8220;<font style="font-style: italic;">Incorporation of Certain Information by Reference</font>&#8221; before making your investment decision. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We are responsible for the information contained in this prospectus. We have not, and the Selling Stockholders have not, authorized anyone to provide you with different information, and we take no, and the Selling Stockholders take no, responsibility for any other information others may give you. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the Selling Stockholders are not, making an offer to sell the Warrant Shares in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in this prospectus is accurate as of any date other than the date on the front of this prospectus. Our business, financial condition, results of operations, and prospects may have changed since that date. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Unless otherwise indicated, information contained in or incorporated by reference into this prospectus concerning our business and the industry and markets in which we operate, including with respect to our business prospects, our market position and opportunity, and the competitive landscape, is based on information from our management&#8217;s estimates, as well as from industry publications, surveys, and studies conducted by third parties. Our management&#8217;s estimates are derived from publicly available information, their knowledge of our business and industry, and assumptions based on such information and knowledge, which they believe to be reasonable. In addition, while we believe that information contained in the industry publications, surveys, and studies has been obtained from reliable sources, we have not independently verified any of the data contained in these third-party sources, and the accuracy and completeness of the information contained in these sources is not guaranteed. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Although we are not aware of any misstatements regarding the market and industry data presented in this prospectus and the documents incorporated herein by reference, these estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#8220;Risk Factors&#8221; in this prospectus and any related free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus, including in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 31, 2026, which is incorporated by reference into this prospectus in its entirety, as well as any amendment or updates to our risk factors reflected in subsequent filings with the SEC. Accordingly, you should not place undue reliance on this information. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">ii<br></div></div></div>
<!--End Page 4-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_104-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tFLS"><!--Anchor--></a>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">This prospectus and any accompanying prospectus supplement contain forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), that are forward-looking and as such are not historical facts. These forward-looking statements include, without limitation, statements regarding Momentus&#8217; or its management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the future, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, and are not guarantees of future performance. The words &#8220;may,&#8221; &#8220;will,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;future,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;aim,&#8221; &#8220;strive,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;contemplate,&#8221; &#8220;objective,&#8221; &#8220;target,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this prospectus may include, for example, statements about: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Momentus&#8217; strategy, future operations, projected capital resources and financial position, estimated revenues and losses, projected costs and capital expenditures, prospects, and plans; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the potential future capabilities of Momentus&#8217; technology, including its water plasma propulsion technology; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">projections of market growth and size; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">anticipated progress and timeline of any testing of Momentus&#8217; technology and any launch status of Momentus&#8217; satellite transportation systems; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expansion plans and opportunities; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the outcome of any known and unknown litigation and regulatory proceedings. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ability of the Company to finance its operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the ability of the Company to obtain licenses and government approvals for its missions, which are essential to its operations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the ability of the Company to effectively market and sell satellite transport services and planned in-orbit services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ability of the Company to protect its intellectual property and trade secrets; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the development of markets for satellite transport and in-orbit services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the ability of the Company to develop, test and validate its technology, including its water plasma propulsion technology; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">delays or impediments that the Company may face in the development, manufacture and deployment of next generation satellite transport systems; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ability of the Company to convert backlog or inbound inquiries into revenue; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in applicable laws or regulations and extensive and evolving government regulations that impact operations and business, including export control license requirements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ability to attract or maintain a qualified workforce with the required security clearances and requisite skills; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">level of product service or product or launch failures or delays that could lead customers to use competitors&#8217; services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">investigations, claims, disputes, enforcement actions, litigation and/or other regulatory or legal proceedings; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Momentus&#8217; compliance with Nasdaq listing requirements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and/or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">other risks and uncertainties described in this prospectus, including those under the section titled &#8220;<font style="font-style: italic;">Risk&#160;Factors</font>.&#8221; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">iii<br></div></div></div>
<!--End Page 5-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_104-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">The forward-looking statements contained in this prospectus are based on our current expectations and beliefs concerning future developments and their potential effects on our business. There can be no assurance that future developments affecting our business will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in the section entitled &#8220;Risk&#160;Factors.&#8221; Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all such risk factors, nor can we assess the effect of all such risk factors on our business or the extent to which any factor or combination of factors may cause actual results to differ materially from those contained in any forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of the assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The forward-looking statements made by us in this prospectus and any free writing prospectus speak only as of the date of this prospectus and any free writing prospectus. Except to the extent required under the federal securities laws and rules and regulations of the SEC, we disclaim any obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events. In light of these risks and uncertainties, there is no assurance that the events or results suggested by the forward-looking statements will in fact occur, and you are cautioned not to place undue reliance on these forward-looking statements. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">iv<br></div></div></div>
<!--End Page 6-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20070923x1_s3_105-summary_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPS"><!--Anchor--></a>PROSPECTUS SUMMARY </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The following summary highlights selected information contained elsewhere in this prospectus and does not contain all of the information that you should consider in making your investment decision. Before investing in our securities, you should carefully read this entire prospectus, the registration statement of which this prospectus is a part and the documents incorporated by reference herein, including the information set forth under the heading &#8220;Risk Factors&#8221; and our consolidated financial statements and the related notes herein.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">The Company </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Momentus is a U.S. commercial space company that offers satellites, satellite buses, and other satellite components, transportation and infrastructure services, including hosted payloads and other in-orbit services to help enable the commercialization of space. Satellite operators are our principal customers and target customers. Momentus offers satellites and satellite buses and technology designed to meet the specific needs of government and commercial customers. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We provide or plan to provide satellites, satellite buses, solar arrays, and other satellite components. Our satellites and satellite technologies offer competitive advantages to customers such as greater payload capability, significant on-orbit power, flexibility of design and the ability to accommodate a range of sensors, communications equipment, and other space instruments, low cost, and speed of delivery.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We are developing an innovative Tape Spring Solar Array (&#8220;TASSA&#8221;) that has the potential to produce power at substantially lower cost than competing solar arrays. TASSA also has important advantages in its ability to be deployed and retracted to protect the array from in-space collisions with debris and to easily maneuver the satellite to different locations or adjust its characteristics.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Over the past several years, Momentus has developed other innovative technologies, such as our Microwave Electrothermal Thruster (&#8220;MET&#8221;) that uses water as a propellant, designed to efficiently accomplish missions such as transportation of customer payloads and small satellites to custom orbits. The MET&#8217;s water propellant is safe, environmentally-friendly, and easy to transport and handle, in contrast to the highly-toxic and difficult to handle propellants commonly used in the space industry. The MET has high specific impulse, or ISP, which is a measure of efficiency, making it well-suited for transportation missions with significantly higher thrust than missions more suitable for low thrust electric propulsion. The MET has been successfully demonstrated on orbit and we have matured this technology to Technology Readiness Level 9, the highest level, with hundreds of successful firings in space during our missions. We have designed our satellite buses and Orbital Service Vehicles to use this innovative technology, while also implementing a modular design that enables Momentus to incorporate high-thrust chemical thrusters or electric thrusters instead of the MET for missions with different requirements.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We provide or plan to provide services, including &#8220;last mile&#8221; satellite transportation, payload-hosting, on-orbit satellite refueling, on-orbit inspection, on-orbit satellite maintenance, de-orbiting, debris removal, and other satellite-to-satellite service offerings. We believe our planned service offerings will increase deployment options for satellite operators and lower their operating costs relative to traditional approaches while also minimizing environmental impact when utilizing our MET with water as a propellant.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We plan to provide these services with Orbital Service Vehicles (&#8220;OSVs&#8221;) that we design and manufacture. While we plan to eventually operate a family of progressively larger and more capable OSVs, we are currently focused onVigoride, which was originally designed to operate in low-Earth orbit (&#8220;LEO&#8221;), but is undergoing enhancements designed to allow it to operate in Geostationary-Earth Orbit (&#8220;GEO&#8221;), Lunar, and Deep Space orbits. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We believe that Vigoride has the ability to deliver fast, versatile, and cost-effective transportation and infrastructure services to our customers. We conducted our inaugural test and demonstration mission with Vigoride in 2022. Momentus has launched four missions to date, deployed 17 customer satellites, and provided hosted payload services. Three of these missions involved operation of the Vigoride OSV in orbit. During these three Vigoride missions, the system and technology were tested repeatedly. Improvements based on lessons learned during these missions were rapidly incorporated. As a result of these three missions, the Vigoride OSV has been successfully demonstrated in space and accumulated significant flight heritage. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our transportation service offering focuses on delivering our customers&#8217; satellites to precision orbits. To accomplish this, we partner with leading launch service providers, such as SpaceX, to &#8220;ride share&#8221; our customer&#8217;s satellites from Earth to space on a midsized or large rocket. Customer satellites can also be carried aboard small launch vehicles for dedicated missions. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 7-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20070923x1_s3_105-summary_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Our OSVs would then provide &#8220;last mile&#8221; transportation services from the rocket&#8217;s drop-off orbit to a custom orbit of the satellite operator&#8217;s choosing. We believe this &#8220;hub-and-spoke&#8221; model has the potential to expand our customers&#8217; deployment options relative to what they would be able to achieve with ride share launch alone, while reducing their costs relative to what they could achieve with a dedicated small launch vehicle. Our OSVs are currently expendable, meaning they are used to perform services before they de-orbit themselves upon completion of their mission. However, our goal is to eventually make our OSVs reusable, or capable of remaining in space to conduct follow-on missions, which has the potential to lower our cost of delivering services to our customers. To achieve reusability, we need to develop additional technologies that will allow our vehicles to locate and navigate to customer satellites in space, physically connect to them, and perform a variety of robotic operations including fluid transfer. The first of these technologies is related to Rendezvous and Proximity Operations (&#8220;RPO&#8221;) which is the ability for the OSV to locate and maneuver to another object in space. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In 2025, the U.S. Air Force Research Labs SpaceWERX organization&#8212;which is the innovation arm of the U.S. Space Force&#8212;awarded Momentus a Direct to Phase II Small Business Innovation Research (&#8220;SBIR&#8221;) contract. The award supports the in-space flight demonstration of a novel, low-cost multi-spectral sensor suite for RPO, scheduled for early 2026. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We are also offering variants of our Vigoride OSV to government and commercial customers as a traditional bus manufacturer and satellite prime contractor. Vigoride, and its variants, M-500 and M-1000, are being offered to support missions such as communication, sensing and tracking of missiles, positioning, navigation, and timing (&#8220;PNT&#8221;) as well as payload technology demonstrations. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Momentus offers or plans to offer production and operation of small satellites to meet a range of defense, government, and commercial needs such as communications, tracking of missiles, remote sensing, and space domain awareness. There is a growing need for such capabilities for defense, government, and commercial customers. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Momentus is offering high-volume production of buses, based on Vigoride&#8217;s technologies, for hosted payloads by integrating customer&#8217;s unique payloads for a variety of missions and for customer-owned satellites for use in constellations. A hosted payload is a module attached to a satellite that can be operated independently from the main spacecraft but which shares the satellite&#8217;s power supply and communications equipment. Hosted payloads are often used by commercial and government customers seeking to operate or test a capability for uses such as communications and sensing in orbit without having to pay the cost of building and launching an entire satellite. Using a hosted payload on a commercial satellite can reduce both the expense and time required to get communications and other technologies into space. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our Vigoride OSVs are intended to provide safe, affordable, reliable, and regular in-space services to our customers, including space transportation, payload hosting, and in-orbit servicing. We designed our Vigoride vehicle to deliver small customer payloads anywhere in LEO. However, we also plan to design and produce larger vehicles and satellite buses to carry larger payloads to more distant orbits such as GEO.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">We currently plan to offer the following infrastructure services to the space economy: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Satellites and Constellation Bus:</font> Momentus offers or plans to offer production and operation of small satellites to meet a range of defense, government, and commercial needs such as communications, tracking of missiles, remote sensing, and space domain awareness. Technologies used to support the Hosted Payload market are directly applicable to offering customer-owned satellites for use in constellations. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Satellite Technologies:</font> Momentus is developing and plans to offer satellite technologies such as our Tape Spring Solar Array, 3D printed propulsion tanks, and other components used on the Vigoride OSV. These technologies and components have been flown in space, or are scheduled to be flown in space, and offer important competitive advantages such as lower cost and flexibility to meet the needs of owners and operators of satellites.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Space Transportation:</font> Momentus offers a transportation service to deliver customers&#8217; satellites to precision orbits. Under this model, our customers would deliver their payload to us a few months prior to launch for integration onto our vehicle. Once we have integrated our customers&#8217; payloads, we would then ship our vehicle, holding the customer payload, to the launch site, where it would be integrated onto the launch vehicle. The launch vehicle would then transport our vehicle to the drop-off orbit. After separation from the launch vehicle, our OSV would transport our customers&#8217; payloads to their chosen final orbit. </div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 8-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20070923x1_s3_105-summary_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">We believe our transportation service has the potential to expand our customers&#8217; deployment options relative to what they could achieve with ride share launch alone, while reducing their costs relative to what they could achieve with a dedicated small launch vehicle.</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Hosted Payload:</font> There are a broad range of payloads, satellite components, and other space technologies, that customers want to operate, test, or validate in space. During development of a satellite component or other system, testing and validation of performance are important, particularly in the harsh environment of space. In other cases, customers wish to operate technologies such as solar collection and energy transmission systems in space without the expense of developing a full system that includes the satellite bus hosting these instruments. Momentus&#8217; hosted payload service allows customers to operate, test, and validate the performance of the technology or system in space at lower cost and less complexity. Momentus&#8217; service offers the ability to manage the integration and operation of these payloads in space. Additionally, Momentus is able to obtain necessary government licenses and manage the integration of these hosted payloads onto our OSV.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">In-Orbit Servicing:</font> As the number of satellites in space increases, so does their need to be serviced. We are actively developing and testing Momentus&#8217; vehicles to be capable of performing in-orbit servicing. We plan to equip future vehicles with robotic arms and an ability to maneuver in close proximity to other spacecraft and grapple, dock, or berth with them. We believe these capabilities could allow us to offer a suite of different in-orbit services, such as inspection, refueling, life extension, re-positioning, salvage missions, maintenance and repair, and de-orbiting.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-weight: bold;">Satellite Bus:</font> Technologies used to support the hosted payload market are directly applicable to offering customer-owned satellite buses for use in constellations. Momentus is offering high-volume production of low-cost buses, based on Vigoride&#8217;s technologies, and integrating customers&#8217; unique payloads for a variety of missions ranging from communications to Earth Observation. We introduced variants of Vigoride tailored specifically for constellation applications as M-500 and M-1000 in August 2023. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">For a further description of the risks associated with our business, see &#8220;Risk Factors.&#8221; Investors are cautioned to review the following description of Momentus&#8217; business together with the entirety of this prospectus, including the within-mentioned risk factors. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Nasdaq Compliance </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our Common Stock is currently listed for quotation on the Nasdaq Capital Market. We are required to meet Nasdaq listing rules in order to maintain such listing. As previously reported, the Company received a series of letters from the Listing Qualifications Staff of Nasdaq (the &#8220;Staff&#8221;) beginning March 27, 2024 with respect to the Company&#8217;s failure to comply certain requirements for continued listing according to the rules of Nasdaq, specifically in regards to the Company&#8217;s stockholders equity, which non-compliance ultimately resulted in the Staff issuing a delisting determination letter on September 24, 2024 (the &#8220;Delisting Determination Letter&#8221;). As permitted by Nasdaq rules, the Company timely requested a hearing before a Nasdaq Hearing Panel (the &#8220;Panel&#8221;) to appeal Nasdaq&#8217;s delisting determination and received a stay of the suspension of trading and delisting of the Common Stock pending the conclusion of the hearing process. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">On January 13, 2025, the Company received a letter issued by the Panel granting the Company&#8217;s request to continue its listing on Nasdaq until April 15, 2025 while the Company executes its plan to regain compliance with the requirements of Nasdaq Listing Rule 5550(b). Additionally, the Panel confirmed that the Company has regained compliance with the Minimum Bid Price Requirement, as set forth in Nasdaq Listing Rule 5550(a)(2), as a result of the Reverse Stock Split the Company effected on December 12, 2024. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">As disclosed in the Company&#8217;s Current Report on Form 8-K filed on April 14, 2025, on April 12, 2025, the Company entered into the Master Services Agreement with Velo3D, Inc. (&#8220;VLD&#8221;), a provider of additive manufacturing solutions, also referred to as 3D printing, pursuant to which VLD will provide services to design and produce components and systems that will be utilized by the Company or its customers in its spacecraft, systems, and components. In exchange for the services, the Company issued an aggregate of 26,749 shares of Common Stock and 673,408 shares of non-voting Series A Preferred Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">On June 24, 2025, the Company announced that it had received a letter from Nasdaq providing written confirmation that the Company has regained compliance with the Equity Rule. Nasdaq has indicated that if the Company&#8217;s stockholder&#8217;s equity as of June 30, 2025 included in the Company&#8217;s Quarterly Report for the quarter ended June 30, 2025 does not show a stockholder&#8217;s equity of $2,500,000, the Company may again be subject to delisting from Nasdaq. In the </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 9-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20070923x1_s3_105-summary_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Company&#8217;s Quarterly Report for the quarter ended June 30, 2025, filed with the SEC on August 19, 2025, the Company reported a stockholders&#8217; deficit of approximately $9.97 million. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Master Services Agreement provided for the cancellation of shares of the Company&#8217;s capital stock held by VLD in certain circumstances upon expiration or termination. On August 14, 2025, the Company irrevocably waived its right under the Master Services Agreement to cancel such shares upon expiration or termination of the Master Services Agreement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In the Company&#8217;s Annual Report for the fiscal year ended December 31, 2025, filed with the SEC on March 31, 2026, the Company reported a stockholders&#8217; equity of approximately $17.1&#160;million. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Going Concern Uncertainty </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our consolidated financial statements are prepared assuming that the Company will continue as a going concern. The going concern basis of presentation assumes that the Company will continue in operation one year after the date the consolidated financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. The Company&#8217;s ability to continue as a going concern is dependent on the Company&#8217;s ability to successfully raise capital to fund its business operations and execute on its business plan. To date the Company remains heavily focused on growth and continued development of its proprietary technology, and as a result, it has not generated sufficient revenues to provide cash flows that enable the Company to finance its operations internally. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Pursuant to the requirements of ASC Sub-Topic 205-40, <font style="font-style: italic;">Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern</font>, management must evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to continue as a going concern for one year from the date the consolidated financial statements are issued. This evaluation does not take into consideration the potential mitigating effect of management&#8217;s plans that have not been fully implemented or are not within control of the Company as of the date the consolidated financial statements are issued. When substantial doubt exists, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company&#8217;s ability to continue as a going concern. The mitigating effect of management&#8217;s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the consolidated financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In connection with the preparation of the consolidated financial statements for the year ended December&#160;31, 2025, management conducted an evaluation and concluded that, without taking into consideration the potential mitigating effect of management&#8217;s plans that have not been fully implemented or are not within control of the Company, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to fund its regular operations, scaling of commercial production, and maintain its existing services and products as a going concern for one year from the date the consolidated financial statements are issued. In the event the Company is unable to raise additional financing, the following plans alleviate the substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the date of the issuance of such financial statements: (i) collection of amounts as they come due under customer contracts, (ii) monetization of unutilized capacity under the Master Services Agreement with Velo3D, Inc.; (iii) reduction of employee headcount and compensation expenses; and (iv) reduction of outside vendor expenses. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">While the Company believes these actions provide sufficient liquidity for its current operating plans, additional capital will be required in the future to support operations and growth initiatives and achieve profitability, and there can be no assurance that such capital will be available on acceptable terms or at all. The Company&#8217;s ability to continue as a going concern is dependent on the Company&#8217;s ability to successfully raise capital to fund its business operations and execute on its business plan. To date, the Company has not generated sufficient revenues to provide cash flows that enable the Company to finance its operations internally. This is reflected by the Company&#8217;s incurred net losses of $30.5&#160;million for the year ended December&#160;31, 2025, and an accumulated deficit of $438.6&#160;million as of December&#160;31, 2025. Additionally, the Company used net cash of $23.3&#160;million to fund its operating activities for the year ended December&#160;31, 2025, and had cash and cash equivalents of $12.8&#160;million as of December&#160;31, 2025. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">As a result of management&#8217;s plans, management has concluded that its mitigation plans alleviate the substantial doubt about the Company&#8217;s ability to continue as a going concern for at least one year from the date the consolidated financial </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 10-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20070923x1_s3_105-summary_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">statements are issued. However, If the Company is unable to raise substantial additional capital in the near term, the Company&#8217;s operations and business plan will need to be scaled back or halted altogether. Additionally, if the Company is able to raise additional capital but that capital is insufficient to provide a bridge to full commercial production at a profit, the Company&#8217;s operations could be severely curtailed or cease entirely and the Company may not realize any significant value from its assets. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">January 2026 Private Placement </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">On January&#160;5, 2026, the Company engaged in a private placement pursuant to which the Company agreed with an investor (the &#8220;January PIPE Investor&#8221;) to sell and issue to such stockholder (i) pre-funded warrants to purchase up to 925,926 shares of Common Stock (the &#8220;January&#160;2026 Pre-Funded Warrants&#8221;), and (ii) warrants to purchase up to 925,926 shares of Common Stock (the &#8220;January&#160;2026 Common Warrants&#8221;). </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The purchase price of each January&#160;2026 Pre-Funded Warrant equals $5.39999, and the exercise price of each January&#160;2026 Pre-Funded Warrant equals $0.00001 per share. The January&#160;2026 Pre-Funded Warrants are exercisable at any time after their original issuance and will not expire until exercised in full. The January 2026 Common Warrants have an exercise price per share of Common Stock equal to $5.40 per share. The January&#160;2026 Common Warrants will be exercisable immediately following receipt of shareholder approval and will expire five years from the initial exercise date. The exercise price and the number of shares of Common Stock issuable upon exercise of the January&#160;2026 Common Warrants is subject to appropriate adjustments in the event of certain stock dividends and distributions, stock splits, stock combinations, reclassifications or similar events affecting the Common Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In connection with the private placement, on January&#160;5, 2028, the Company entered into a Placement Agency Agreement with the Placement Agent. As part of its compensation for acting as Placement Agent for the private placement, the Company paid the Placement Agent a cash fee of 7.0% of the aggregate gross proceeds and also agreed to issue to the warrants to purchase up to 46,296 shares of Common Stock (the &#8220;January&#160;2026 PA Warrants&#8221;) at an exercise price of $5.94, which are exercisable on or after July 6, 2026. The January 2026 PA Warrants have a term of five years from January&#160;6, 2026. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Company received aggregate gross proceeds from the private placement of approximately $5 million, before deducting placement agent commissions and expenses in connection with the private placement, which were paid by the Company. After deducting the approximately $0.42 million paid to the Placement Agent pursuant to the Placement Agency Agreement, the Company received approximately $4.58 million in proceeds from the private placement. The Company agreed to use the net proceeds from the private placement for general corporate purposes, which may include repayment of principal on the Company&#8217;s indebtedness, capital expenditures, and funding its working capital needs. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Also in connection with the private placement, the Company and the January&#160;2026 PIPE Investor agreed to reduce the exercise price of certain warrants issued to the 2026 PIPE Investor on October&#160;15, 2025 and December 11, 2025 from $13.74 per share to $5.40 per share. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">April 2026 Private Placement </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">On April&#160;14, 2026, the Company engaged in a private placement pursuant to which the Company agreed with an investor (the &#8220;April PIPE Investor&#8221;) to sell and issue to such stockholder (i) 450,000 shares of Common Stock (the &#8220;April&#160;2026 Private Placement Shares&#8221;) and (ii) pre-funded warrants to purchase up to 883,334 shares of Common Stock (the &#8220;April&#160;2026 Pre-Funded Warrants&#8221;). </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The purchase price of each April&#160;2026 Private Placement Share equals $3.75. The purchase price of each April&#160;2026 Pre-Funded Warrant equals $3.74999, and the exercise price of each April&#160;2026 Pre-Funded Warrant equals $0.00001 per share. The April&#160;2026 Pre-Funded Warrants are exercisable at any time after their original issuance and will not expire until exercised in full. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In connection with the private placement, on April&#160;14, 2026, the Company entered into a Placement Agency Agreement with the Placement Agent. As part of its compensation for acting as Placement Agent for the private placement, the Company paid the Placement Agent a cash fee of 7.0% of the aggregate gross proceeds and also agreed to issue to the warrants to purchase up to 66,666 shares of Common Stock (the &#8220;April&#160;2026 PA Warrants&#8221;) at an exercise price of $4.125, which are exercisable on or after October&#160;11, 2026. The April&#160;2026 PA Warrants have a term of five years from April&#160;15, 2026. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Company received aggregate gross proceeds from the private placement of approximately $5&#160;million, before deducting placement agent commissions and expenses in connection with the private placement, which were paid by the </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 11-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20070923x1_s3_105-summary_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Company. After deducting the approximately $0.42 million paid to the Placement Agent pursuant to the Placement Agency Agreement, the Company received approximately $4.58 million in proceeds from the private placement. The Company agreed to use the net proceeds from the private placement for general corporate purposes, which may include repayment of principal on the Company&#8217;s indebtedness, capital expenditures, and funding its working capital needs. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">2025 Reverse Stock Split </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In order to maintain compliance with the Minimum Bid Price Requirement, on December 3, 2025, the board of directors of the Company approved a reverse stock split ratio of 1-for-17.85 approved by the stockholders of the Company on September 17, 2025 (the &#8220;Reverse Stock Split&#8221;). The Reverse Stock Split was effective as of 5:00 p.m. Eastern Time on December&#160;17, 2025. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Implications of Being a Smaller Reporting Company </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">As a company with less than $100 million of annual revenue in our most recently completed fiscal year and the market value of our stock held by non-affiliates as of June 30, 2024, was less than $700 million, we qualify as a &#8220;smaller reporting company&#8221; as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended. A smaller reporting company may take advantage of specified reduced reporting requirements that are otherwise applicable generally to public companies. These reduced reporting requirements include, but are not limited to, reduced disclosure about our executive compensation arrangements and an exemption from the requirements to obtain a non-binding advisory vote on golden parachute arrangements. Accordingly, the information contained herein may be different from the information you receive from other public companies in which you hold stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Corporate Information </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We were incorporated in the State of Delaware in May 2019 as a special purpose acquisition company under the name Stable Road Acquisition Corp. On November 13, 2019, we completed our initial public offering. On August 12, 2021, we consummated a business combination with Legacy Momentus pursuant to that Agreement and Plan of Merger, dated October 7, 2020. In connection with such business combination, we changed our name from Stable Road Acquisition Corp. to Momentus Inc. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our principal executive offices are located at 1762 Automation Parkway, San Jose, California 95131. Our telephone number is (650) 564-7820. Our website address is www.momentus.space. Information contained on our website or connected thereto does not constitute part of, and is not incorporated by reference into, this prospectus or the registration statement of which it forms a part. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Momentus, the Momentus logo and our other registered or common law trademarks, service marks or trade names appearing in this prospectus are the property of Momentus. Other trademarks, service marks and trade names used in this prospectus are the property of their respective owners. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 12-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20070923x1_s3_105-summary_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tOFF"><!--Anchor--></a>THE OFFERING </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 228pt; margin-top: 7pt; margin-left: 0pt; text-align: left;">Common stock offered by the Selling Stockholder<font style="font-weight: normal; padding-left: 2.07pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 252pt; text-align: justify;">Up to 1,400,000 shares of Common Stock consisting of (i)&#160;450,000 Private Placement Shares (i) 883,334 Pre-Funded Warrant Shares issuable to the Selling Stockholders upon the exercise of the Pre-Funded Warrants; and (iii) 66,666 PA Warrant Shares issuable to the Selling Stockholders upon exercise of the PA Warrants. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 228pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Terms of the offering<font style="font-weight: normal; padding-left: 3.62pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 252pt; text-align: justify;">The Selling Stockholders will determine when and how they will sell the Shares offered in this prospectus, as described in &#8220;Plan of Distribution.&#8221; </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 228pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Use of proceeds<font style="font-weight: normal; padding-left: 3.04pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 252pt; text-align: justify;">We will not receive any proceeds from the sale of the Shares covered by this prospectus. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 228pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Risk Factors<font style="font-weight: normal; padding-left: 3.35pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 252pt; text-align: justify;">See &#8220;Risk Factors&#8221; and other information included in this prospectus for a discussion of factors you should consider before investing in our securities. </div><div class="BRDSX_sum1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; width: 228pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">Nasdaq Stock Market Symbols<font style="font-weight: normal; padding-left: 3.58pt;"></font></div><div class="BRDSX_sum2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -12pt; margin-left: 252pt; text-align: justify;">Our Common Stock is listed on the Nasdaq Capital Market under the symbol &#8220;MNTS.&#8221;</div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 13-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_106-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Investing in our Common Stock involves a high degree of risk. Prior to making a decision about investing in our Common Stock, you should consider carefully the specific risk factors discussed in this section and above under &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221;, under the heading &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 31, 2026, which is incorporated by reference into this prospectus in its entirety, as well as any amendment or updates to our risk factors reflected in subsequent filings with the SEC, including any prospectus supplement hereto or any related free writing prospectus. These risks and uncertainties are not the only risks and uncertainties we face. Additional risks and uncertainties not presently known to us, or that we currently view as immaterial, may also impair our business. If any of the risks or uncertainties described in our SEC filings or any additional risks and uncertainties actually occur, our business, financial conditions, results of operations, stock price and prospectus could be materially and adversely affected. In that even, the price of our Common Stock could decline, and you could lose part or all of your investment. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">We may not currently or in the future be able to continue as a going concern. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The financial statements incorporated by reference in this prospectus have been prepared on a going concern basis of accounting which assumes that we will continue as a going concern, and do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company&#8217;s ability to continue as a going concern is dependent on the Company&#8217;s ability to generate revenues and raise capital. To date, the Company has not generated sufficient revenues to provide cash flows that enable the Company to finance its operations internally. In connection with an evaluation conducted by the Company&#8217;s management during the preparation of this report, management concluded that there were conditions and events which raised substantial doubt as to the Company&#8217;s ability to continue as a going concern within twelve months after the date of the issuance of the financial statements included in this report. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The uncertainty regarding our ability to continue as a going concern could materially adversely affect our share price and our ability to service our indebtedness, raise new capital or enter into commercial transactions. To address these matters, the Company may take actions that materially and adversely affect our business, including significant reductions in research, development, administrative and commercial activities, reduction of our employee base, and ultimately curtailing or ceasing operations, any of which could materially adversely affect our business, financial condition, results of operations and share price. In addition, doubts about our ability to continue as a going concern could impact our relationships with customers, vendors and other third parties and our ability to obtain, maintain or renew contracts with them, or negatively impact our negotiating leverage with such parties, which could have a material adverse effect on our business, financial condition and results of operations. Furthermore, any loss of key personnel, employee attrition or material erosion of employee morale arising out of doubts about our ability to operate as a going concern could have a material adverse effect on our ability to effectively conduct our business and could impair our ability to execute our strategy and implement our business objectives, thereby having a material adverse effect on our business, financial condition and results of operations. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">If we fail to comply with the continued listing requirements of Nasdaq we face possible delisting, which would result in a limited public market for our shares and make obtaining future debt or equity financing more difficult for us. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">On September 24, 2024, the Company received a letter from the Listing Qualifications Staff of Nasdaq indicating that the Company was subject to delisting for failure to satisfy Nasdaq&#8217;s requirements for continued listing set forth in Nasdaq Listing Rule 5550(a)(2) (the &#8220;Minimum Bid Price Requirement&#8221;). The Company had also received deficiency letters on May 23, 2024 and August 21, 2024, respectively, from the Staff notifying the Company that the Company had not filed its Form 10-Q for the periods ending March 31, 2024 and June 30, 2024, respectively, as required for continued listing on the Nasdaq under Nasdaq Listing Rule 5250(c)(1) (the &#8220;Periodic Reporting Requirement&#8221;). Pursuant to Nasdaq Listing Rule 5810(d)(2), the failures to comply with the Periodic Reporting Requirement individually became additional and separate bases for delisting. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">On October 15, 2024, the Company filed its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024, resolving the deficiencies related to the Periodic Reporting Requirement. On October 17, 2024, the Company received further notice from the Listing Qualifications Department of Nasdaq notifying the Company that it was not in compliance with the requirements of Nasdaq Listing Rule 5550(b) as a result of not having a minimum of $2,500,000 in stockholders&#8217; equity for continued listing as of June 30, 2024, a market value of listed securities of at least $35 million, or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two&#160;of the last three most recently completed fiscal years (the &#8220;Equity Rule&#8221;). </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 14-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_106-risk_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">As permitted by Nasdaq rules, the Company timely requested a hearing before a Nasdaq Hearing Panel to appeal Nasdaq&#8217;s delisting determination. The Company requested and received a stay of the suspension of trading and delisting of the Common Stock pending the conclusion of the hearing process, which allowed the Common Stock to remain listed on Nasdaq at least until the Panel renders a decision following the hearing. The hearing before the Panel was held on November 14, 2024, at which the Company requested a suspension of delisting pending its return to compliance. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Company called a special meeting of stockholders on December 2, 2024, to approve a reverse stock split to regain compliance with Nasdaq rules. On December 12, 2024, the Company effected a 1-for-14 reverse stock split, and on December 27, 2024, the Company&#8217;s Common Stock closed above the minimum bid price for ten consecutive trading days as required to regain compliance with the Minimum Bid Price Requirement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">On January 13, 2025, the Company received a letter issued by the Panel granting the Company&#8217;s request to continue its listing on Nasdaq until April 15, 2025 while the Company executed its plan to regain compliance with the requirements of the Equity Rule. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">As disclosed in the Company&#8217;s Current Report on Form 8-K filed on April 14, 2025, on April 12, 2025, the Company entered into the Master Services Agreement with VLD, pursuant to which VLD will provide services to design and produce components and systems that will be utilized by the Company or its customers in its spacecraft, systems, and components. In exchange for the services, the Company issued an aggregate of 26,749 shares of Common Stock and 673,408 shares of non-voting Series A Convertible Preferred Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">On June 24, 2025, the Company announced that it had received a letter from Nasdaq providing written confirmation that the Company has regained compliance with Nasdaq&#8217;s rules. Nasdaq has indicated that if the Company&#8217;s stockholder&#8217;s equity as of June 30, 2025 included in the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 does not show a stockholder&#8217;s equity of at least $2,500,000, then the Company may again be subject to delisting from Nasdaq. In the Company&#8217;s Quarterly Report for the quarter ended June 30, 2025, filed with the SEC on August 19, 2025, the Company reported a stockholders&#8217; deficit of approximately $9.97 million. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Master Services Agreement with VLD provided for the cancellation of shares of the Company&#8217;s capital stock held by VLD in certain circumstances upon expiration or termination. On August 14, 2025, the Company irrevocably waived its right under the Master Services Agreement to cancel such shares upon expiration or termination of the Master Services Agreement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In order to maintain compliance with the Minimum Bid Price Requirement, the Company effected a reverse stock split of the Common Stock at a ratio of 1-for-17.85, which went into effect at 5:00 p.m. Eastern Time on December&#160;17, 2025. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In the Company&#8217;s Annual Report for the fiscal year ended December&#160;31, 2025, filed with the SEC on March&#160;31, 2026, the Company reported a stockholders&#8217; equity of approximately $17.1&#160;million. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">There can be no assurance that the Company will be able to maintain compliance with the Equity Rule, the Minimum Bid Price Requirement, the Periodic Reporting Requirement, or other applicable Nasdaq listing rules, that the Company will be able to successfully implement a reverse stock split if it decides to pursue one, that the Panel will grant any future request from the Company for a suspension of delisting on Nasdaq, or that the Company&#8217;s appeal of a delisting determination will be successful. Additionally, if we fail to meet the Minimum Bid Price Requirement, we are not eligible for a 180-day cure period from Nasdaq to regain compliance with such requirement because we have conducted a reverse stock split in the past year and thus we would be immediately delisted. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">If at the time of filing of the Company&#8217;s next periodic financial statements the Company does not evidence compliance with the Equity Rule, the Company may again be subject to delisting from Nasdaq. If the Common Stock loses its listing on the Nasdaq Capital Market, the Common Stock would likely trade in the over-the-counter market. If the Common Stock were to trade on the over-the-counter market, selling the Common Stock could be more difficult because smaller quantities of shares would likely be bought and sold, transactions could be delayed, and security analysts&#8217; coverage of us may be reduced. In addition, in the event the Common Stock is delisted, broker-dealers have certain regulatory burdens imposed upon them, which may discourage broker-dealers from effecting transactions in the Common Stock, further limiting the liquidity of such shares. A determination that the Common Stock is a &#8220;penny stock&#8221; would require brokers trading in the Common Stock to adhere to even more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for the Common Stock. These factors could result in lower prices and larger spreads in the bid and ask prices for the Common Stock. Such delisting from the Nasdaq Capital Market and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 15-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_106-risk_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">continued or further declines in the price of shares of the Common Stock could also greatly impair our ability to raise additional necessary capital through equity or debt financing, and could significantly increase the ownership dilution to stockholders caused by our issuing equity in financing or other transactions. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">We have a substantial number of convertible securities outstanding. The exercise of our outstanding warrants and conversion of our outstanding convertible notes can have a dilutive effect on our Common Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have a substantial number of convertible securities outstanding. The exercise of our outstanding warrants and conversion of our convertible notes will likely have a dilutive effect on our Common Stock. The issuance of shares of Common Stock upon exercise of outstanding options or warrants or conversion of Preferred Stock could result in substantial dilution to our stockholders, which may have a negative effect on the price of our Common Stock. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">We need additional capital and any additional capital we seek may not be available in the amount or at the time we need it. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We need to raise funds in the future to execute our business plan. We may seek to raise additional capital to expand our business, pursue strategic investments, and take advantage of financing or other opportunities that we believe to be in our best interests and the interests of our stockholders. Additional capital may be raised through the sale of common or preferred equity or convertible debt securities, entry into debt facilities or other third-party funding arrangements. The sale of equity and convertible debt securities may result in dilution to our stockholders and those securities may have rights senior to those of the Common Stock. Agreements entered into in connection with such capital raising activities could contain covenants that would restrict our operations or require us to relinquish certain rights. Additional capital may not be available on reasonable terms, or at all. If we cannot timely raise any needed funds, we may be forced to reduce our operating expenses, which could adversely affect our ability to implement our long-term strategic roadmap and grow our business. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">The market price of the Common Stock has been, and may continue to be, volatile, which could reduce the market price of the Common Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The publicly traded shares of the Common Stock have experienced, and may experience in the future significant price and volume fluctuations. During the 12 months ended April 17, 2026, the market price of the Common Stock as reported by Nasdaq has ranged from a high of $43.56 per share to a low of $3.11 per share. This market volatility could reduce the market price of the Common Stock without regard to our operating performance. In addition, the trading price of the Common Stock could change significantly in response to actual or anticipated variations in our quarterly operating results, announcements by us or our competitors, factors affecting the space transportation industry generally, changes in national or regional economic conditions, changes in securities analysts&#8217; estimates for us or our competitors&#8217; or industry&#8217;s future performance or general market conditions, making it more difficult for shares of the Common Stock to be sold at a favorable price or at all. The market price of the Common Stock could also be reduced by general market price declines or market volatility in the future or future declines or volatility in the prices of stocks for companies in our industry. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Future sales and issuances of the Common Stock could cause our stock price to fall. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Sales of a substantial number of shares of the Common Stock by our existing stockholders in the public market, or the perception that these sales might occur, could depress the market price of the Common Stock and could impair our ability to raise additional capital through the issuance of additional equity securities. We are unable to predict the effect that such sales may have on the prevailing market price of the Common Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Any issuance of equity we may undertake in the future to raise additional capital could cause the price of the Common Stock to decline, or require us to issue shares at a price that is lower than that paid by holders of the Common Stock in the past, which would result in those newly issued shares being dilutive. In addition, future investors could gain rights superior to existing stockholders, such as liquidation and other preferences. If we obtain funds through a credit facility or through the issuance of debt or preferred securities, these securities will likely have rights senior to the rights of a common stockholder, which could impair the value of the Common Stock. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We also have stock options and warrants outstanding to purchase shares of our capital stock. Our stockholders may incur dilution upon exercise of any outstanding stock options and warrants. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 16-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_107-use_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUOP"><!--Anchor--></a>USE OF PROCEEDS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We will not receive any of the proceeds from the sale of the Shares by the Selling Stockholders pursuant to this prospectus. We will bear all fees and expenses incident to our obligation to register such shares. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 17-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_108-stock_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSS"><!--Anchor--></a>SELLING STOCKHOLDERS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">This prospectus covers the resale or other disposition by the Selling Stockholders identified in the table below of the Shares, consisting of up to an aggregate of 1,400,000 shares of Common Stock. The Selling Stockholders acquired the Shares in the transaction described above under the heading &#8220;Prospectus Summary&#8212;April&#160;2026 Private Placement.&#8221; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Pre-Funded Warrants provide that the Selling Stockholders will not have the right to exercise any portion of the Pre-Funded Warrants if such exercise would cause the aggregate number of shares of Common Stock beneficially owned by the applicable Selling Stockholder (together with its affiliates) to exceed 9.99% (the &#8220;Pre-Funded Warrant Ownership Limitation&#8221;) of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Pre-Funded Warrants. By written notice to the Company, a Selling Stockholder may decrease or increase the Pre-Funded Warrant Ownership Limitation to any other percentage, provided that in no event can the Pre-Funded Warrant Ownership Limitation exceed 9.99%. Any such increase will not be effective until the 61st day after such notice is delivered to the Company by the Selling Stockholders. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The PA Warrants provide that the Selling Stockholders will not have the right to exercise any portion of the PA Warrants before October 11, 2026. In addition, the PA Warrants provide that the Selling Stockholders will not have the right to exercise any portion of the PA Warrants if such exercise would cause the aggregate number of shares of Common Stock beneficially owned by the applicable Selling Stockholder (together with its affiliates) to exceed 4.99% (the &#8220;PA Warrant Ownership Limitation&#8221;) of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the PA Warrants. By written notice to the Company, a Selling Stockholder may decrease or increase the PA Warrant Ownership Limitation to any other percentage, provided that in no event can the PA Warrant Ownership Limitation exceed 9.99%. Any such increase will not be effective until the 61st day after such notice is delivered to the Company by the Selling Stockholders. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">The table below sets forth, as of April 17, 2026, the following information regarding the Selling Stockholders: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Name of the Selling Stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Number of shares of Common Stock beneficially owned by the Selling Stockholders prior to exercise of the Warrants; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Number of shares of Common Stock issuable upon the exercise of the Warrants; </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The number of shares owned are those beneficially owned, as determined under the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">All information with respect to the Common Stock ownership of the Selling Stockholders has been furnished by or on behalf of the Selling Stockholders. We believe, based on information supplied by the Selling Stockholders, that except as may otherwise be indicated in the footnotes to the table below, the Selling Stockholders have sole voting and dispositive power with respect to the shares of Common Stock reported as beneficially owned by the Selling Stockholders. Because the Selling Stockholders identified in the table may sell some or all of the shares of Common Stock beneficially owned by them and covered by this prospectus, and because there are currently no agreement, arrangements, or understanding with respect to the sale of any of the shares of Common Stock, no estimate can be given as to the number of shares of Common Stock available for resale hereby that will be held by the Selling Stockholders upon termination of this offering. In addition, the Selling Stockholders may have sold, transferred or otherwise disposed of, or may sell, transfer or otherwise dispose of, at any time from time to time, the shares of Common Stock they beneficially own in transactions exempt from the registration requirements of the Securities Act after the date on which it provided the information set forth in the table below. We have, therefore, assumed for the purposes of the following table, that the Selling Stockholders will sell all of their respective shares of Common Stock owned beneficially by them that are covered by this prospectus, but will not sell any other shares of Common Stock that they presently own. Except as set forth below, the Selling Stockholders have not held any position or office, or has otherwise had a material relationship, with us or any of our subsidiaries within the past three years other than as a result of the ownership of our shares of Common Stock or other securities. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">12<br></div></div></div>
<!--End Page 18-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_108-stock_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 84.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 66.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 70.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 49.38pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 168pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name of Selling Stockholder</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 84.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number Beneficially <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Owned Prior to Offering</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 66.57pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number Registered <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">for Sale Hereby</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 70.28pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number Beneficially <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Owned After <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Offering</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.38pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Percent <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Owned <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">After Offering </div></td></tr><tr><td style="width: 168pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Citadel CEMF Investments Ltd.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.44pt;"></font></div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 84.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.25pt; text-align: left;">1,333,334<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 66.57pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.28pt; text-align: left;">1,333,334<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 70.28pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.39pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.38pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.94pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">A.G.P. / Alliance Global Partners<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup><font style="padding-left: 4.29pt;"></font></div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 84.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.25pt; text-align: left;"><font style="padding-left: 7.5pt;">120,774</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 66.57pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.28pt; text-align: left;"><font style="padding-left: 12.5pt;">66,666</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 70.28pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 21.39pt; text-align: left;">54,108<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.38pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.94pt; text-align: left;">0.81%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 84.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 66.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 70.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.38pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 16pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The securities are directly held by Citadel CEMF Investments Ltd. Citadel Advisors LLC is the portfolio manager of Citadel CEMF Investments Ltd. Citadel Advisors Holdings LP, or &#8220;CAH&#8221;, is the sole member of Citadel Advisors LLC. Citadel GP LLC, or &#8220;CGP&#8221;, is the general partner of CAH. Kenneth Griffin owns a controlling interest in CGP. Mr. Griffin, as the owner of a controlling interest in CGP, may be deemed to have shared power to vote or direct the vote of, and/or shared power to dispose or to direct the disposition over, the securities. This disclosure is not and shall not be construed as an admission that Mr. Griffin or any of the Citadel related entities listed above is the beneficial owner of any securities of the Company other than the securities actually owned by such person (if any). The address of Citadel CEMF Investments Ltd. is c/o Citadel Enterprise Americas LLC, 830 Brickell Plaza, Floor 15, Miami, Florida 33131. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 450,000 shares of Common Stock and (ii) 883,334 shares of Common Stock issuable to the Selling Stockholder upon exercise of the Pre-Funded Warrants. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 450,000 shares of Common Stock and (ii) 883,334 shares of Common Stock issuable to the Selling Stockholder upon exercise of the Pre-Funded Warrants. The Pre-Funded Warrants are subject to a beneficial ownership limitation of 9.99%, which such limitation restricts the Selling Stockholders from exercising that portion of the warrants that would result in the Selling Stockholders and their respective affiliates owning, after exercise, a number of shares of Common Stock in excess of the beneficial ownership limitation </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Assuming the sale of all securities offered hereby. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The securities are directly held by A.G.P./Alliance Global Partners. The address of A.G.P./Alliance Global Partners is 590 Madison Avenue, 28th Floor, New York, New York 10022. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 66,666 shares of Common Stock issuable to the Selling Stockholder upon exercise of the PA Warrants; and (ii) 54,108 shares of Common Stock issuable to the Selling Stockholder upon exercise of certain warrants. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of 66,666 shares of Common Stock issuable to the Selling Stockholder upon exercise of the PA Warrants. None of the PA Warrants may be exercised prior to October&#160;11, 2026. In addition, the PA Warrants are subject to a beneficial ownership limitation of 4.99% (or, at the election of the applicable Selling Stockholder, 9.99%), which such limitation restricts the Selling Stockholders from exercising that portion of the warrants that would result in the Selling Stockholders and their respective affiliates owning, after exercise, a number of shares of Common Stock in excess of the beneficial ownership limitation </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">13<br></div></div></div>
<!--End Page 19-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_109-plan_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPOD"><!--Anchor--></a>PLAN OF DISTRIBUTION </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Selling Stockholders and any of their respective pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on Nasdaq or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling Stockholders may use any one or more of the following methods when selling securities: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">block trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">purchases by a broker-dealer as principal and resale by the broker-dealer for its account; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an exchange distribution in accordance with the rules of the applicable exchange; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">privately negotiated transactions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">settlement of short sales; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">in transactions through broker-dealers that agree with the applicable Selling Stockholder to sell a specified number of such securities at a stipulated price per security; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a combination of any such methods of sale; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any other method permitted pursuant to applicable law. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), if available, rather than under this prospectus. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Broker-dealers engaged by the applicable Selling Stockholder may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the applicable Selling Stockholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">In connection with the sale of the securities or interests therein, the applicable Selling Stockholder may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The applicable Selling Stockholder may also sell securities short and deliver these securities to close out its short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The applicable Selling Stockholder may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Applicable Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. The Selling Stockholders have informed the Company that they do not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">14<br></div></div></div>
<!--End Page 20-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_109-plan_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The securities covered hereby will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the securities may not simultaneously engage in market making activities with respect to the Common Stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the securities by the applicable Selling Stockholder or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act). </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">15<br></div></div></div>
<!--End Page 21-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 22-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_110-legal_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">The validity of the securities offered hereby will be passed upon for us by Bradley Arant Boult Cummings LLP. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tEXP"><!--Anchor--></a>EXPERTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The consolidated financial statements of the Company and subsidiaries as of and for the years ended December 31, 2025 and 2024, incorporated by reference in this prospectus, have been audited by Frank, Rimerman + Co. LLP, an independent registered public accounting firm, as stated in their report. Such consolidated financial statements are incorporated by reference in reliance upon the report of such firm given their authority as experts in accounting and auditing. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We are subject to the periodic reporting requirements of the Exchange Act, and we will file periodic reports, proxy statements and other information with the SEC. These periodic reports, proxy statements and other information are available at www.sec.gov. We also maintain a website at <font style="font-style: italic;">www.momentus.space</font>, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only. We will provide you without charge, upon your oral or written request, with a copy of any or all reports, proxy statements and other documents we file with the SEC, as well as any or all of the documents incorporated by reference in this prospectus or the registration statement (other than exhibits to such documents unless such exhibits are specifically incorporated by reference into such documents). Requests for such copies should be directed to: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;">Momentus Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Attn: John C. Rood <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Chief Executive Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">1762 Automation Parkway <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">San Jose, CA 95131 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Telephone: (650) 564-7820 </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">16<br></div></div></div>
<!--End Page 22-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 23-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_111-incorp_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tICI"><!--Anchor--></a>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The SEC allows us to &#8220;incorporate by reference&#8221; information from other documents that we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus, and information that we file later with the SEC will automatically update and superseded this information. Information in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We incorporate by reference into this prospectus the information or documents listed below that we have filed with the SEC (Commission File No. 001-39128): </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2025, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000162828026022291/mnts-20251231.htm">March&#160;31, 2026</a>; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our Definitive Proxy Statement on Schedule 14A, filed with the Commission on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000114036126014277/ny20066708x1_def14a.htm">April&#160;10, 2026</a>; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the description of our Common Stock contained in <a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125014782/ny20047547x1_ex4-19.htm">Exhibit&#160;4.19</a> to our Registration Statement on Form&#160;S-1, as filed with the SEC on April&#160;21, 2025, and including any further amendment or report filed for the purpose of updating such description; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our Current Reports filed on Form&#160;8-K with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000114036126000853/ef20062616_8k.htm">January&#160;9, 2026</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000114036126001016/ef20062613_8k.htm">January&#160;13, 2026</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000114036126004972/ef20065509_8k.htm">February&#160;12, 2026</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000114036126006335/ef20066258_8k.htm">February&#160;20, 2026</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000114036126014365/ef20070362_8k.htm">April&#160;13, 2026</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000114036126014988/ef20070575_8k.htm">April&#160;16, 2026</a>, and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1781162/000114036126015530/ef20070972_8k.htm">April&#160;20, 2026</a>. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">All reports and other documents that we file with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Exchange Act on or after the date of the initial registration statement and prior to effectiveness of the registration statement, and on or after the date of this prospectus but before the termination of the offering of the securities hereunder will also be considered to be incorporated by reference into this prospectus from the date of the filing of these reports and documents, and will supersede the information herein; provided, however, that all reports, exhibits and other information that we &#8220;furnish&#8221; to the SEC will not be considered incorporated by reference into this prospectus. We undertake to provide without charge to each person (including any beneficial owner) who receives a copy of this prospectus, upon written or oral request, a copy of all of the preceding documents that are incorporated by reference (other than exhibits, unless the exhibits are specifically incorporated by reference into these documents). You may request a copy of these materials in the manner set forth under the heading &#8220;<font style="font-style: italic;">Where You Can Find More Information</font>,&#8221; above. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">17<br></div></div></div>
<!--End Page 23-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 24-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20070923x1_s3_300-bcv_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_block-frill" style="width: 456pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 150.75pt; text-align: center;"><img style="height: 153px; width: 168px;" src="logo_momentus3x1.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 67.5pt; text-align: center;">Up to 1,400,000 Shares of Common Stock<font style="font-weight: normal;"> </font></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 29.5pt; text-align: center;">PRELIMINARY PROSPECTUS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 288pt; text-align: center;">&#8195;&#8195;&#8195;&#8195;, 2026</div></div></div><div class="BRDSX_block-frill" style="width: 456pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 24-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 25-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_301-part2_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">PART II<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">INFORMATION NOT REQUIRED IN PROSPECTUS </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 14.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Other Expenses of Issuance and Distribution. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The following is an estimate of the expenses (all of which are to be paid by the registrant) that we may incur in connection with the securities being registered hereby. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 420pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 420pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 420pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">SEC registration fee<font style="padding-left: 1.41pt;"></font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">1,379 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Legal fees and expenses<font style="padding-left: 0.6pt;"></font></div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$15,000 </div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounting fees and expenses<font style="padding-left: 1.71pt;"></font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$40,000 </div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Miscellaneous<font style="padding-left: 4.74pt;"></font></div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">5,000 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="padding-left: 2.09pt;"></font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$61,379</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 420pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 15.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Indemnification of Directors and Officers. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Section 145 of the Delaware General Corporation Law (the &#8220;DGCL&#8221;) provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise. The DGCL provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitled under any bylaws, agreement, vote of stockholders or disinterested directors or otherwise. The registrant&#8217;s Second Amended and Restated Certificate of Incorporation, as amended, and Amended and Restated Bylaws, as amended, provide for indemnification by the registrant of its directors and officers to the fullest extent permitted by the DGCL. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Section 102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (1) for any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders, (2) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3) for unlawful payments of dividends or unlawful stock repurchases, redemptions or other distributions, or (4) for any transaction from which the director derived an improper personal benefit. The registrant&#8217;s Second Amended and Restated Certificate of Incorporation, as amended, provides for such limitation of liability to the fullest extent permitted by the DGCL. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The registrant has entered into, and expects to continue to enter into, indemnification agreements with each of its directors and executive officers. These agreements provide that the registrant will indemnify each of its directors and such officers to the fullest extent permitted by law. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Any underwriting agreement or distribution agreement that the registrant enters into with any underwriters or agents involved in the offering or sale of any securities registered hereby may require such underwriters or dealers to indemnify the registrant, some or all of its directors and officers and its controlling persons, if any, for specified liabilities, which may include liabilities under the Securities Act. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The registrant also maintains standard policies of insurance under which coverage is provided to its directors and officers against loss arising from claims made by reason of breach of duty or other wrongful act, while acting in their capacity as directors and officers of the registrant. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-1<br></div></div></div>
<!--End Page 25-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 26-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_301-part2_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 16.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Exhibits and Financial Statement Schedules. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 414pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 48pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exhibit <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Description of Exhibit </div></td></tr><tr><td style="width: 48pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125035600/ny20047547x30_ex1-1.htm">1.2</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales Agreement,dated September&#160;19, 2025, by and between Momentus Inc. and Alliance Global Partners (incorporated by reference to Exhibit&#160;1.1 to the Company&#8217;s Current Registration Statement on Form&#160;S-3 filed on September&#160;22, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000121390020030403/ea127854ex2-1_stableroad.htm">2.1</a>&#8224;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Agreement and Plan of Merger,dated as of October&#160;7, 2020, by and among Stable Road Acquisition Corp., Project Marvel First Merger Sub, Inc., Project Marvel Second Merger Sub, LLC, and Momentus Inc. (incorporated by reference to Exhibit&#160;2.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on October&#160;7, 2020). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000121390021013894/fs42021a2_stableroadacq.htm#T110">2.2</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment No. 1 to Agreement and Plan of Merger,dated March&#160;5, 2021, by and among Stable Road Acquisition Corp., Project Marvel First Merger Sub, Inc., Project Marvel Second Merger Sub, LLC, and Momentus Inc. (incorporated by reference to Exhibit&#160;2.2 to the Company&#8217;s Registration Statement on Form&#160;S-4 (Registration No. 333-249787) filed on March&#160;8, 2021). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000121390021020806/ea139255ex2-1_stableroad.htm">2.3</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment No. 2 to Agreement and Plan of Merger ,dated as of April&#160;6, 2021, by and among Stable Road Acquisition Corp., Project Marvel First Merger Sub, Inc., Project Marvel Second Merger Sub, LLC, and Momentus Inc. (incorporated by reference to Exhibit&#160;2.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on April&#160;8, 2021). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000121390021034706/ea143483ex2-1_stableroad.htm">2.4</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment No. 3 to Agreement and Plan of Merger, dated as of June&#160;29, 2021, by and among Stable Road Acquisition Corp., Project Marvel First Merger Sub, Inc., Project Marvel Second Merger Sub, LLC, and Momentus Inc. (incorporated by reference to Exhibit&#160;2.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on June&#160;29, 2021). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000121390019023186/f8k1119ex4-1_stableroad.htm">4.1</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrant Agreement, dated November&#160;7, 2019,between Continental Stock Transfer &amp; Trust Company and SRAC (incorporated by reference to the Company&#8217;s Current Report on Form&#160;8-K filed on November&#160;13, 2019). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000121390019020151/fs12019a1ex4-3_stable.htm">4.2</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Specimen Warrant Certificate (incorporated by reference to Exhibit&#160;4.3 to the Company&#8217;s Registration Statement on Form&#160;S-1 (Registration No. 333-233980) filed on October&#160;10, 2019). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036124041174/ef20035903_ex4-2.htm">4.3</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Class&#160;A Warrant (incorporated by reference to Exhibit&#160;4.2 to the Company&#8217;s Current Report on Form&#160;8-K filed on September&#160;16, 2024). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036124049586/ny20039820x3_ex4-1.htm">4.4</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on December&#160;16, 2024). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036124049848/ny20039383x5_ex4-1.htm">4.5</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Common Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on December&#160;18, 2024). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036124049848/ny20039383x5_ex4-3.htm">4.6</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Placement Agent Warrant (incorporated by reference to Exhibit&#160;4.3 to the Company&#8217;s Current Report on Form&#160;8-K filed on December&#160;18, 2024). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125004114/ef20043284_ex4-1.htm">4.7</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Common Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on February&#160;13, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125004114/ef20043284_ex4-3.htm">4.8</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment to Common Stock Purchase Warrants (incorporated by reference to Exhibit&#160;4.3 to the Company&#8217;s Current Report on Form&#160;8-K filed on February&#160;13, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125004114/ef20043284_ex4-4.htm">4.9</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Placement Agent Warrant (incorporated by reference to Exhibit&#160;4.4 to the Company&#8217;s Current Report on Form&#160;8-K filed on February&#160;13, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125009817/ef20045953_ex4-1.htm">4.10</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Inducement Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on March&#160;21, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125014782/ny20047547x1_ex4-19.htm">4.11</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Description of Securities (incorporated by reference to Exhibit&#160;4.19 to the Company&#8217;s Registration Statement on Form&#160;S-1 filed on April&#160;21, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125020988/ny20047547x5_ex4-12.htm">4.12</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Common Stock Purchase Warrant (incorporated by reference to Exhibit&#160;4.12 to the Company&#8217;s Registration Statement on Form&#160;S-1 (Registration No. 333-287712) filed on May&#160;30, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125024623/ny20047547x22_ex4-1.htm">4.13</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Common Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on July&#160;2, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125024623/ny20047547x22_ex4-2.htm">4.14</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Pre-Funded Warrant (incorporated by reference to Exhibit&#160;4.2 to the Company&#8217;s Current Report on Form&#160;8-K filed on July&#160;2, 2025). </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 414pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-2<br></div></div></div>
<!--End Page 26-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 27-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_301-part2_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 414pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 48pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exhibit <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Description of Exhibit </div></td></tr><tr><td style="width: 48pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125024623/ny20047547x22_ex4-3.htm">4.15</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment to Common Stock Purchase Warrants (incorporated by reference to Exhibit&#160;4.3 to the Company&#8217;s Current Report on Form&#160;8-K filed on July&#160;2, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125031042/ef20053912_ex4-1.htm">4.16</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Inducement Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on August&#160;14, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125034600/ef20055431_ex10-1.htm">4.17</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Class&#160;A Common Stock Purchase Warrant (incorporated by reference to Exhibit&#160;C to Exhibit&#160;10.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on September&#160;11, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125036535/ny20047547x33_ex4-1.htm">4.18</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Junior Secured Convertible Note&#160;Due September&#160;25, 2026, dated September&#160;25, 2025, between Momentus Inc. and Yield Point NY, LLC (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on September&#160;29, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125036535/ny20047547x33_ex4-2.htm">4.19</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Common Stock Purchase Warrant, dated September&#160;25, 2025, between Momentus Inc. and Yield Point NY, LLC (incorporated by reference to Exhibit&#160;4.2 to the Company&#8217;s Current Report on Form&#160;8-K filed on September&#160;29, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125036535/ny20047547x33_ex4-3.htm">4.20</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">AIR Warrant, dated September&#160;25, 2025, between Momentus Inc. and Yield Point NY, LLC (incorporated by reference to Exhibit&#160;4.3 to the Company&#8217;s Current Report on Form&#160;8-K filed on September&#160;29, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125036535/ny20047547x33_ex4-4.htm">4.21</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pre-Funded Common Stock Purchase Warrant, dated September&#160;25, 2025, between Momentus Inc. and Yield Point NY, LLC (incorporated by reference to Exhibit&#160;4.4 to the Company&#8217;s Current Report on Form&#160;8-K filed on September&#160;29, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125037391/ny20047547x36_ex4-1.htm">4.22</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pre-Funded Common Stock Purchase Warrant, dated September&#160;30, 2025, between Momentus Inc. and Baker &amp; McKenzie LLP (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on October&#160;6, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125038203/ef20057132_ex4-1.htm">4.23</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Inducement Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on October&#160;15, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036125045310/ef20061056_ex4-1.htm">4.24</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Inducement Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on December&#160;12, 2025). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036126000853/ef20062616_ex4-1.htm">4.25</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Pre-Funded Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on January&#160;9, 2026). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036126000853/ef20062616_ex4-2.htm">4.26</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Common Warrant (incorporated by reference to Exhibit&#160;4.2 to the Company&#8217;s Current Report on Form&#160;8-K filed on January&#160;9, 2026). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036126014988/ef20070575_ex4-1.htm">4.27</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Pre-Funded Warrant (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Current Report on Form&#160;8-K filed on April&#160;16, 2026). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1781162/000114036126014988/ef20070575_ex4-2.htm">4.28</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Placement Agent Warrant (incorporated by reference to Exhibit&#160;4.2 to the Company&#8217;s Current Report on Form&#160;8-K filed on April&#160;16, 2026). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20070923x1_ex5-1.htm">5.1*</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Opinion of Bradley Arant Boult Cummings LLP. </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20070923x1_ex23-1.htm">23.1*</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Frank, Rimerman + Co. LLP, independent registered public accounting firm. </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20070923x1_ex5-1.htm">23.2*</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Bradley Arant Boult Cummings LLP (included in Exhibit&#160;5.1). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPOA">24.1*</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Power of Attorney (included on the signature page to the prospectus which forms part of this registration statement). </div></td></tr><tr><td style="width: 48pt; padding-top: 1.01pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20070923x1_ex107.htm">107*</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 414pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Filing Fee Table.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 414pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 16pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Filed herewith </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#8224;<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Certain of the exhibits and schedules to this Exhibit List have been omitted in accordance with Regulation S-K Item 601(a)(5). The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 17.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Undertakings. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The undersigned registrant hereby undertakes: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-3<br></div></div></div>
<!--End Page 27-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 28-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_301-part2_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona&#160;fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or our securities provided by or on behalf of the undersigned registrant; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-4<br></div></div></div>
<!--End Page 28-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 29-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_301-part2_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-5<br></div></div></div>
<!--End Page 29-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 30-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20070923x1_s3_302-sig_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">SIGNATURES </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized on April 21, 2026. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 276pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td colspan="4" style="width: 276pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 240pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 216pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>MOMENTUS INC.</u><font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Lon Ensler<font style="font-style: normal;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Lon Ensler </div></td></tr><tr><td style="width: 240pt; padding-top: 0.26pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 0.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Title:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Financial Officer</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;"><a name="tPOA"><!--Anchor--></a>POWER OF ATTORNEY </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints John C. Rood and Lon Ensler, and each and either of them, as his true and lawful agent, proxy and attorney-in-fact, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to act on, sign and file any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto and any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act together with all schedules and exhibits thereto, to act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, act on and file any supplement to any prospectus included in this registration statement or any such amendment or any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act, and take any and all actions which may be necessary or appropriate to be done, as fully for all intents and purposes as he might or could do in person, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-fact or any of his substitutes may lawfully do or cause to be done by virtue thereof. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates indicated. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 144pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Signature</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Title</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date </div></td></tr><tr><td style="width: 144pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ John C. Rood</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Chief Executive Officer and Director <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"><font style="font-style: italic;">(Principal Executive Officer)</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April 21, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">John C. Rood </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Lon Ensler</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Chief Financial Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"><font style="font-style: italic;">(Principal Financial and Accounting Officer)</font></div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April 21, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Lon Ensler </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Brian Kabot</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April 21, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brian Kabot </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April 21, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chris Hadfield </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Kimberly A. Reed</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April 21, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Kimberly A. Reed </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Linda J. Reiners</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April 21, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Linda J. Reiners </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Mitchel B. Kugler</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April 21, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Mitchel B. Kugler </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 144pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 72pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 144pt; height: 12.5pt; padding-top: 0.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Victorino Mercado</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 228pt; height: 12.5pt; padding-top: 0.26pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 72pt; height: 12.5pt; padding-top: 0.26pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April 21, 2026 </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Victorino Mercado</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 72pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-6<br></div></div></div>
<!--End Page 30-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ny20070923x1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center">Exhibit 5.1</div>
    <div><br>
    </div>
    <div><img src="ny20070923x1_ex5-1img01.jpg" width="179" height="60"></div>
    <div><br>
    </div>
    <div style="text-align: center; margin-left: 4.3pt;">April 21, 2026</div>
    <div><br>
    </div>
    <div>Momentus Inc.</div>
    <div>1762 Automation Parkway</div>
    <div>San Jose, CA 95131</div>
    <div>(650) 564-7820</div>
    <div><br>
    </div>
    <div>Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: justify;">We have acted as counsel to Momentus Inc., a Delaware corporation (the &#8220;<u>Corporation</u>&#8221;), with respect to certain legal matters in connection with the filing with the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;)



      of a registration statement on Form S-3 (the &#8220;<u>Registration Statement</u>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<u>Securities Act</u>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify;"> The Registration Statement relates to the issuance by the Corporation of up to (i) 450,000 shares (the &#8220;<u>Shares</u>&#8221;) of the Corporation&#8217;s Class A common stock, par value $0.00001 (&#8220;<u>Common
          Stock</u>&#8221;), issued to Citadel CEMF Investments Ltd. (&#8220;<u>Citadel</u>&#8221;) pursuant to a securities purchase agreement dated April 14, 2026 (the &#8220;<u>SPA</u>&#8221;); (ii) 883,334 shares of Common Stock issuable upon
      exercise of that certain common stock pre-funded warrant issued by the Corporation to Citadel on April 15, 2026 (the &#8220;<u>Pre-Funded Warrant</u>&#8221;); and (iii) 66,666 shares of Common Stock issuable upon the exercise of that certain common
      stock purchase warrant issued by the Corporation to A.G.P. / Alliance Global Partners on April 15, 2026 (the &#8220;<u>Placement Agent Warrant</u>&#8221; and, together with the Pre-Funded Warrant, the &#8220;<u>Warrants</u>&#8221;) (the shares of
      Common Stock issuable upon exercise of the Warrants, collectively, the &#8220;<u>Warrant Shares</u>&#8221; and the shares of Common Stock registered pursuant to the Registration Statement, collectively, the &#8220;<u>Securities</u>&#8221;).<br>
    </div>
    <br>
    <div style="text-align: justify;"><font style="color: #000000;">In connection with this opinion, we have examined and relied upon </font>the originals, or copies certified or otherwise identified to our satisfaction, of<font style="color: #000000;">
        (i) the Second Amended and Restated Certificate of Incorporation of the Corporation, as amended to date (the &#8220;<u>Certificate of Incorporation</u>&#8221;); (ii) the Amended and Restated Bylaws of the Corporation, as amended to date (the &#8220;<u>Bylaws</u>&#8221;);
        (iii) certain resolutions of the Board of Directors of the Corporation; (iv) the Warrants; (v) the SPA; (vi) the Registration Statement; and (vii) </font>such records, documents, certificates, and other instruments as in our judgment are necessary
      or appropriate to enable us to render the opinion expressed below<font style="color: #000000;">.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify;">For purposes of this opinion, we have assumed, and express no opinion as to, the authenticity of original documents and the genuineness of all signatures, the conformity to the originals of all documents submitted to
      us as copies, the truth, accuracy and completeness of the information, representations and warranties contained in the instruments, documents, certificates and records we have reviewed, the legal capacity of all natural persons or entities (except
      for the Corporation), the absence of any undisclosed termination, modification, waiver or amendment to any document reviewed by us, the absence of any other extrinsic agreements or documents that might change or affect the interpretation or terms of
      documents we have reviewed, and the due authorization, execution and delivery of all such documents where due authorization, execution and delivery are prerequisites to the effectiveness thereof. As to any facts material to the opinions expressed
      herein that were not independently established or verified, we have relied upon oral or written statements and representations of officers and other representatives of the Corporation.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Based upon and subject to the foregoing, and the further limitations set forth below, we are of the opinion that:</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify;">
      <div>
        <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z71febc8a739e4f10adedf774ea4757d5" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt;">1.</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">The Shares are validly issued, fully paid and nonassessable.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify;">
      <div>
        <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z95cc1aa1cf354b4cb2fd163a91d60057" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 36pt; vertical-align: top; text-align: right;">
                <div style="text-align: left; margin-left: 18pt;">2.</div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div style="text-align: justify;">The Warrant Shares have been duly and validly authorized for issuance and, when issued and delivered by the Corporation upon valid exercise of the Warrants, in accordance with and in the manner described in
                  the Registration Statement and the Warrants, the Warrant Shares will be validly issued, fully paid and nonassessable.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: center; font-size: 8pt; font-family: Arial,Helvetica,'sans-serif';">Bradley Arant Boult Cummings LLP | ONE 22 ONE | 1221 Broadway | Suite 2400 | Nashville, TN 37203 | 615.244.2582 | bradley.com</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: justify; color: #000000;">Our opinion expressed above is subject to the qualifications that we express no opinion as to the applicability of, compliance with, or effect of any laws except the Delaware General Corporation Law
        (&#8220;<u>DGCL</u>&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">We do not find it necessary for the purposes of this opinion, and accordingly we do not purport to cover herein, the application of the securities or &#8220;Blue Sky&#8221; laws of the various states to the
        issuance of the Securities.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">This opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated herein. Our opinion expressed above is made as of the date
        hereof and is subject to, and may be limited by, future changes in the factual matters set forth herein, and we undertake no duty to advise you of the same. The opinion set forth herein is based upon the law in effect (and published or otherwise
        generally available) on the date hereof, and we assume no obligation to revise or supplement this opinion should such law be changed by legislative action, judicial decision or otherwise. In rendering our opinion, we have not considered, and hereby
        disclaim any opinion as to, the application or impact of any laws, cases, decisions, rules or regulations of any other jurisdiction, court or administrative agency.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">This opinion is furnished to you in connection with the filing of the Registration Statement in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">We hereby consent to the filing of this opinion as Exhibit 5.1 to the Registration Statement. We also consent to the reference to our firm under the heading &#8220;Legal Matters&#8221; in the Registration
        Statement. In giving such consent, we do not believe that we are &#8220;experts&#8221; within the meaning of such term as used in the Securities Act or the rules and regulations of the Commission issued thereunder with respect to any part of the Registration
        Statement, including this opinion as an Exhibit.</div>
    </div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd12b1d51f3284df18beb12aa42e11c3c" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>Very truly yours,</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>/s/ Bradley Arant Boult Cummings, LLP</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" noshade="noshade" align="center"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ny20070923x1_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 23.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div><br>
    </div>
    <div style="text-align: justify;">We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 31, 2026, relating to the consolidated financial statements of Momentus Inc. and Subsidiaries,
      appearing in the Annual Report on Form 10-K of Momentus Inc. for the year ended December 31, 2025. We also consent to the reference to our Firm under the caption &#8220;Experts&#8221; in the Registration Statement.</div>
    <div><br>
    </div>
    <div>/s/ Frank, Rimerman + Co. LLP</div>
    <div>San Francisco, California</div>
    <div>April 21, 2026</div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ny20070923x1_ex107.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Tue Apr 21 07:09:06 UTC 2026 -->
<!-- Created by CompSci Resources, LLC on Mon Oct 13 19:35:23 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
 <head>
  <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
 <body><div style="font-family: Times New Roman; font-size: 12pt;"><div>

  </div><hr style="border-top: 4px solid black; border-bottom: none; border-left: none; border-right: none; height: 2px; margin: 8px auto; width: 100%;"/><div style="text-align: right; margin-right: 0.75pt;">
   <span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Exhibit 107</span>
  </div><div>
  </div><div style="margin-bottom: 10pt; margin-top: 10pt; text-align: center;">
   <span style="font-size: 10.0pt; font-weight: bold;">CALCULATION OF FILING FEE TABLE</span>
  </div><div>
  </div><div style="text-align: center;"> <span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Form <ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-141"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-142">S-3</ix:nonNumeric></ix:nonNumeric></span> </div><div>
  </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000;">(Form Type)</span>
  </div><div>
  </div><div style="text-align: center; font-size: 10pt;">&#160;
  </div><div>
  </div><div style="text-align: center;"> <ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-24"><span style="font-size: 10.0pt; color: #000000; font-weight: bold;">Momentus Inc.</span></ix:nonNumeric> </div><div>
  </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000;">(Exact Name of Registrant as Specified in its Charter)</span>
  </div><div>
  </div><div style="text-align: center; margin-right: 0.75pt; font-size: 10pt;">&#160;
  </div><div>
  </div><div style="text-align: center;">
   <span style="font-size: 10.0pt; color: #000000; font-weight: bold; text-decoration: underline;">Table 1: Newly Registered  Securities</span>
  </div><div>




  </div><table style="border-spacing: 0px; border-collapse: collapse; margin-left: -0.25pt; width: 100%; font-size: 10pt;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 10%;">&#160;</td><td style="width: 10%;">&#160;</td><td style="width: 20%;">&#160;</td><td style="width: 10%;">&#160;</td><td style="width: 10%;">&#160;</td><td style="width: 10%;">&#160;</td><td style="width: 10%;">&#160;</td><td style="width: 10%;">&#160;</td><td style="width: 10%;">&#160;</td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Security Type</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 2pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Security Class Title</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 2pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Fee Calculation Rule</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Amount Registered<span style="font-size: .83em; vertical-align: super;">(1)</span></span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Proposed Maximum Offering Price Per Unit</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Maximum Aggregate <br/>Offering Price</span> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Fee Rate</span> </td> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; text-align: center;"> <span style="font-weight: bold;">Amount of Registration Fee</span> </td> </tr> <tr style="vertical-align: top; height: 11pt; background-color: rgb(204, 238, 255);"> <td style="padding: 2pt 1.25pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; height: 11pt;"> <div> <ix:nonNumeric contextRef="c1" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-143">Fees to Be Paid</ix:nonNumeric> </div> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTp" id="ixv-144">Equity</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTitl" id="ixv-145">Class A common stock, $0.00001 par value per
share</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonNumeric contextRef="c1" format="ixt:fixed-true" name="ffd:FeesOthrRuleFlg" id="ixv-146">457(c)</ix:nonNumeric> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:AmtSctiesRegd" scale="0" unitRef="shares" id="ixv-147">1,400,000</ix:nonFraction> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxOfferingPricPerScty" scale="0" unitRef="usdPershares" id="ixv-148">7.13</ix:nonFraction><sup>(2) </sup></td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-149">9,982,000</ix:nonFraction> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-150">0.00013810</ix:nonFraction> </td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-151">1,379</ix:nonFraction> </td> </tr> <tr style="vertical-align: top;"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black;">&#160;</td> <td colspan="4" style="padding: 2pt 5.4pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: right; vertical-align: bottom;"> <span style="font-weight: bold;">Total Offering Amounts</span> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ffd:TtlOfferingAmt" scale="0" unitRef="usd" id="ixv-152">9,982,000</ix:nonFraction> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ffd:TtlFeeAmt" scale="0" unitRef="usd" id="ixv-153">1,379</ix:nonFraction> </td> </tr> <tr style="vertical-align: top; background-color: rgb(204, 238, 255);"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black;">&#160;</td> <td colspan="4" style="padding: 2pt 5.4pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: right; vertical-align: bottom;"> <span style="font-weight: bold;">Total Fees Previously Paid</span> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonFraction contextRef="c0" decimals="0" format="ixt:fixed-zero" name="ffd:TtlPrevslyPdAmt" scale="0" unitRef="usd" id="ixv-154">&#8212;</ix:nonFraction> </td> </tr> <tr style="vertical-align: top; height: 11pt;"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; height: 11pt;">&#160;</td> <td colspan="4" style="padding: 2pt 5.4pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: right; height: 11pt; vertical-align: bottom;"> <span style="font-weight: bold;">Total Fee Offsets</span> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> <ix:nonFraction contextRef="c0" decimals="0" format="ixt:fixed-zero" name="ffd:TtlOffsetAmt" scale="0" unitRef="usd" id="ixv-155">&#8212;</ix:nonFraction> </td> </tr> <tr style="vertical-align: top; height: 11pt; background-color: rgb(204, 238, 255);"> <td style="padding: 0px 5.4pt; border-width: 1pt; border-style: solid; border-color: black; height: 11pt;">&#160;</td> <td colspan="4" style="padding: 2pt 5.4pt 1.75pt 5.4pt; border-width: 1pt; border-style: solid; border-color: black; text-align: right; height: 11pt; vertical-align: bottom;"> <span style="font-weight: bold;">Net Fee Due</span> </td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="padding: 0px 1.25pt 0px 1px; border-width: 1pt; border-style: solid; border-color: black; vertical-align: bottom; font-size: 0px; height: 11pt;">&#160;</td> <td style="border-width: 1pt; border-style: solid; border-color: black; padding: 2pt 1.25pt 1.75pt 1px; vertical-align: bottom; text-align: center; height: 11pt;"> $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ffd:NetFeeAmt" scale="0" unitRef="usd" id="ixv-156">1,379</ix:nonFraction> </td> </tr> </table><ix:nonNumeric contextRef="c1" continuedAt="_OfferingNote-c1_cont_1" escape="true" name="ffd:OfferingNote" id="ixv-110"><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;">&#160;</td><td style="width: 99%;">&#160;</td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">(1)</span> </div> </td> <td style="padding: 0px 5.4pt; text-align: left;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">Pursuant to Rule 416(a) under the Securities Act
of 1933, as amended (the &#8220;<span style="text-decoration:underline">Securities Act</span>&#8221;), this Registration Statement
shall also cover any additional shares of the Registrant&#8217;s Class A common
stock, par value $0.00001 per share (&#8220;<span style="text-decoration:underline">Common Stock</span>&#8221;), that become
issuable by reason of any stock dividend, stock split, recapitalization, or
other similar transaction effected without receipt of consideration that
increases the number of outstanding shares of Common Stock.</span> </div> </td> </tr> </table></ix:nonNumeric><ix:continuation id="_OfferingNote-c1_cont_1"><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;">
   <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;">&#160;</td><td style="width: 99%;">&#160;</td></tr><tr style="vertical-align: top;">
    <td style="padding: 0px 0pt;">
     <div style="margin-bottom: 4pt;">
      <span style="font-size: 10.0pt;">(2)</span>
     </div>
    </td>
    <td style="padding: 0px 5.4pt; text-align: left;">
     <div style="margin-bottom: 4pt;">
      <span style="font-size: 10.0pt;">Estimated in accordance with Rule 457(c) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $7.13 per share, which is the average of the high and low prices of Common Stock on April 16, 2026, as reported on the Nasdaq Capital Market.</span>
     </div>
    </td>
   </tr>
  </table></ix:continuation><div>











  </div><div style="margin-right : 171.75pt; font-size : 8pt; width : 100%; ">&#160;
  </div><div>

 </div><hr style="border-top: 2px solid black; border-bottom: none; border-left: none; border-right: none; height: 2px; margin: 8px auto; width: 100%;"/><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-159">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-160">0001781162</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-161">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-162">N/A</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001781162</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-04-21</xbrli:startDate>
    <xbrli:endDate>2026-04-21</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001781162</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>1</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2026-04-21</xbrli:startDate>
    <xbrli:endDate>2026-04-21</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
<!-- [WMV7][x2/YwRYU0PsAlWBmP8S3sQBYnaWEEdNzXF1SS/SNmpjNkReA11m5tOmeRH2D+La6Btx8TUg3zi3QYGaC4ZSfO9F/TI8ZelYkISCoxY9WJMbJ34AH+Nv74wkV8yGjQuHahBaPaJBKRAbaPVFyW+RvX/HNMGr5tsaVShDWajPu2IEUPG/CUsNTFuNQt4ruBSTYEc5Rjs56m4IzTD4Y8NK0eVGU8VOeUFwKyP216vqIzZ5j7rE3PpIzSAa6H07/oti4O/Ep2N6/PvTp50vae6VL0pfLqwXilsAS9Yxa+EG0yD4DlVBaT1xj3PRipj3c6gAukZUI8rwkMQLgbgjIcFqRUKFNA2OrYU5xomE2] CSR-->
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>logo_momentus3.jpg
<TEXT>
begin 644 logo_momentus3.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M@U\)447?=_U_PR^X#[M_X>D_\%-O^DB_[=O_ (EU^T!_\\&C_AZ3_P %-O\
MI(O^W;_XEU^T!_\ /!KX2HHN^[_K_AE]P'W;_P /2?\ @IM_TD7_ &[?_$NO
MV@/_ )X-'_#TG_@IM_TD7_;M_P#$NOV@/_G@U\)447?=_P!?\,ON ^[?^'I/
M_!3;_I(O^W;_ .)=?M ?_/!H_P"'I/\ P4V_Z2+_ +=O_B77[0'_ ,\&OA*B
MB[[O^O\ AE]P'W;_ ,/2?^"FW_21?]NW_P 2Z_: _P#G@T?\/2?^"FW_ $D7
M_;M_\2Z_: _^>#7PE11=]W_7_#+[@/NW_AZ3_P %-O\ I(O^W;_XEU^T!_\
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M*S>[MK)]7US496ATKPYH%K=7EK%J'B+Q!?:9H6F_:(GU#4;:-P]?U7?L&?\
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MZ*O?&M''5ZO\!O\ DN7P9_[*O\.__4OT>OW(_98_X-VOVF/B>=/\1?M*>+=
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ME\+6B>5HGAC38-,LQI6BZ?IUD6C\,?#WPCI\NI72"[U&/33 NMZU#^K.I?M
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M?';]H/XA>,M"O/)\[P5;ZG%X4^'C&V=GMI&^'G@^WT#P7+=6Y.$U"?0Y=1?
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MZKX2\#ZYJ,R@L'NI@U?VV?!?]E7]FO\ 9TM4M_@9\"OA9\+918P:;<:MX/\
M!6A:5XDU.TMT\N)-<\5169\2^()=N?,NM;U74+J9BSS32.S,?:]7UK1_#VG7
M>L:_JVFZ'I-A#+<WVJ:O?VNFZ=9V\,;RS3W=]>RP6UO#%%&\LLLTJ)'&CNS!
M5)"I<<Y-D[4.%.$,!AJR:C3Q^:3J9ACI-M6<4FJM*3>O+3Q<J;ERV@E%1?@4
M^/,DR6T>%.$,OPE6.D,QS:<\PQK;M[RM*-2C*]WRPQDJ;?+:"C%1?\A'P*_X
M-@_&=X]CJ/[2W[2OAS0;=+A7U#PE\$O#FH>)KR[LB03%!X\\;P^&;;2+X)\K
ML?A]XAM8Y<A'N(U#R?LM\!_^"''_  3C^!7]GWK?!5_C+XCT]I2/$?QXUN?X
M@?;%EC\LQZAX*CM]%^%=VJ L\32> !,DC;Q+E(]GT)\2O^"H'_!/'X2V]S/X
MT_;)_9^2:RF^SW>E>%?B)HGQ#\16LVQY/+N/#'P\G\4^(H6"1DMYFEJ%+1*2
M'GA63\_/B;_P<D_\$T/ C!/">O\ QF^-):,,)/AO\*+_ $>!)&D>,13-\8-4
M^%<Z[0JS2/%;3J(9%\OS9P\"[5,3XL\4W5#!\23P]2Z4<OR[$Y?@^5KX)XBC
M1H0G%I[8C$3;6[:2MXF8\;<:9SS1K9ICJ=&6GL<#'ZA1Y7?W)/"QI3J1=W=5
MJE1O9MI)+]T/"?@_PEX#T#3_  KX&\+>'/!GA?28A!I7AOPGHFF>'= TR =(
M=/T?1[6STZRB':.VMXT_V:Z*OY"OB5_P=:^'()M1M/@_^QOK>JVY6[32?$'Q
M*^+ECX?FC<;EL;C4?!_A?P3XE2522DUW9VWCB$KM:VAOFWBZC^(]=_X.(/\
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M[&L5CJ$+_89_%7A/4_B=\?O@'XL\8)?^+4^!5MXA/B&:3WLMX>JUN6OF$Z>
MPU]'BJD,.WM9S564'"#NN5.TJBNX^[&4C]N\/<B\/LA]CQ5XH8JCF5.FH5\G
MX"P6);Q.924O=QG%%;"U(U\MRN-HNAE%*=+-<UY_;UIY?EU*,LR^#?V>?V6K
M2ULQ\,?A%X*^(WCZ[T/1)?!>L?#/]G2Z\)VWC^7PTVGZ@K>#OCI^U,]YK?[/
M/[&?PUUX'4+_ ,3?"WP%XC^*WQ5U^[\3>+?#WQS\0ZUK4FE:KI/TI<67P3TS
M18/@-\9_VFM#T'P7=F673_\ @FU_P2)\-:_\5O%/CJ\@&G6+Z?\ &[XXV$&O
MZE\1_&[P6J:/XQT;XB>(KB*[N+*TU#PUXAT@QV\*?I7'^P=\6O%>B:;H7B;]
MG>P^*WA/2QIUSH'@7]J[]LV;X6_"SPC<VBHPM],_9+_8A_9TO/V:[NQMO/E$
M5GJ,]]/+<)<BYUJX6&TU#4/I[PC^S+^W%X:\)7'@[X9?%W]AO]CWPW+/=SVW
MA_\ 9N_8NUKQ#)I[7"F.&5-2\7?&WPMX-O=0M(RA&H3_  FBBN9HV>XTXPRB
MV@^LI/)\$HJ>/P-/E<5&<,91E3C))6G3K9?AL]Q2@MD_[)P>,A'FIPQEN64?
MN.-_I&YSQ/4I4Z4EA,%@HX:EEN"R^E@\%@<LA@J:HX&&547AL7@\%A\OH_[/
ME,J61T,XR7 WRO+<\I9=3P]&C\&_!#P]^VEX>T-O"_\ P3@_X)A?!K]A3P1K
M5K?6#_'3]L/Q,;WXMZYI@FEEM'\2^#M$N-=^+^F:M9WC/<V%CXYE^(N@0[HH
M[:!+(!%ZWQ/_ ,$B/C/^T!IUSXD_X*3_ /!27XP_$GP\+6UU/7/AS\*SX?\
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M$MY_PE/['.H>)=%D$5]?>+/'NC_M)?$6RU3309WNX?#MSJ?Q'UOPWJRO ?\
MD6_#FADSXMK:!9)5@?<\9?\ !Q+_ ,$W/#-U8Z%\,]0^-WQ\OYC:V6G:/\&?
M@KKMO<LTA-O#:VEC\4;GX72R"%E@@6*SAFW&>!+1)_G$?Z#^#/\ @F[_ ,$_
M_ "6@\+_ +&'[,UK<6+B2TU/4?@SX$\1:Y;R"26421Z_XCT35M;$@:9P'_M
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MB.75)O[;GO\ ]ICP)<+\%/ DWBV*'YXI?BA\0;GX?^,[^!P#;:+X^MKAU\K
MK_+$N;FYO;FXO+RXGN[N[GEN;JZN99)[FYN9Y&EGN+B>5GEFGFE=I)99&:22
M1F=V9B2:<[6LMU?Y ?[G7_";>#/^AN\,?^#_ $K_ .2ZZ>O\)>O]8O\ X+I_
M\%F-(_X)._!CP?9^ _#OA[XA_M0_&V36X/A3X.\2S7K^%?"WA_PZMHGB'XE^
M/;/1[JQU6\T33[[4M,T?P_X>M]4T&Z\6ZO<WYLM7BLO#.OF$4KIMZ6M^/_!
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M!>QQE1)):2R7"QW"(70.\+.JEE#$%AFG_P )MX,_Z&[PQ_X/]*_^2Z_RZ/\
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MQH[MA5)'^?E_P>=_\G-?L7?]D)\?_P#JP(*_)O\ X-G_ /E-M^Q5_P!W'_\
MK)/QYH<FI6MU7XV_X/\ 6X?ZQU?-WC']LG]D'X=>)G\%?$']JO\ 9N\"^,HV
MC1_"7C'XY?##PQXF1YKB6TA1]!UOQ18ZJK2W<$UK&IM 7N(985!DC=1_GC_\
M''7_  6*_:%^/G[7?QH_8S^$GQ&\6_#/]F+]GOQ1K'P>\4^%O!GB'4?#[?&3
MXC>$]0-A\1-8^(\VE_V?=ZUH6B>+K*Z\,>'/!FH7>I>&H$\+P^*_LQUG5V&G
M_@E^R;^PS^U7^W/KWCSPM^RC\(]0^,7B7X:>#F\?>,- T?Q)X*T36+'PJNI6
MND?;],T[Q=XE\/7?B:Z;4;VUM8]%\+Q:SKDKS*T>FO'N<#GK9*_]= /]I'PM
MXT\'>.=.36/!/BSPSXPTB10T>J>%M>TOQ!ITBF6> ,E]I-U=VSJ9[6YA!64@
MRVT\>=\,BKTM?XNWCK]E3_@HE^P5KFD?%OQO\"OVLOV4M7\,ZT;?PU\9'\&?
M$_X60:3KX:>U1?"_Q8TRTTK38]2E591;R:'XD,]S:R)/;M+:W$4DG^AY_P $
M%?%W_!2S]K7_ ()Y>#OCS^TC^U_X@6\\8>/O&UC\([W6/A1\*O$_B36/@_X/
M_L?P9I^K>)M<N=!TG6-2U:Y\?Z!\1$CU'Q"VK:WJVD0Z7K%SK-]#J%MY0I7=
MK/\ X'X?J!_ER5]$:G^SYK]G^R;X)_:KM%U"\\+^(?VB/BC^SYK[I:C^RO#F
MO^#OAK\(/B/X16>^')U#QIIWCKQN;2U;(%MX!O9DP3)GYWK^K/\ 8*_967]J
MO_@V8_X*0V.G:6FI>-/@)^UW>?M/>!2\SQBQO/@_\$OA+>>/;J.*,%KR[G^"
MVK?%'2M.LP"9]2U*TV!I%13DE?\ '\ /P;\*_MM_%7PI^P7\7?V [#4;Z/X5
M_%?]HKX7_M 7R6]\8+>"]\%^#_%OAWQ3X?O+$1L-0LO&>JI\'/$CNTL8T[4?
MA%I3I',U\[0^<:9^SYK]Y^R;XV_:KNUU"S\+^'OVB/A=^SYH#O:C^RO$>O\
MC'X:_%_XC^+E@OCR-0\%Z=X%\$&[M5P#;>/K*9\D1X^=Z_JS_;V_967]E3_@
MV8_X)O6.HZ6FF^-/CW^UW9_M/>.BDSR"^O/C!\$OBU>> KJ2*0!K.[@^"VD_
M"[2M1LR 8-2TV[WA9&=06W\E?\4OU _E,K^E/_@Z]\=>*?%G_!7/Q?X=U^VO
M;;1OAA\"_@IX,\$/<L3;7WAS4]#O_B-?7^G)]EMU6W_X3#QYXHTZ9O-OV:\T
MVY#7BJB6%C_-97][_P#P=T?\$U_'WCM/A[_P4D^%&CW'B'1_AQX#L?@]^TAH
MNGHC7WAWPM8^)]3U;X<?%."Q@L_M&HZ9!J?C'7/"'CW4);YY]$LU^'UU;Z:^
MBP>)M5TBE>TK>5_37_AP/YF?^""OP@^'OQT_X*[?L2?#SXI:;9ZSX,?XB>*/
M&UUI&I1+<Z;JFM_"?X7>//BOX-T_4K.0-!?Z=>>,_!6@6]_IMW'-8ZE:236%
M_!/9W$\,G^@E_P ')/P:^&'Q4_X)$?M1>(/'^DZ VO\ P?TWP9\2/AAXNU32
MX;W5_!_C.S^(W@[23'X=O6 N=-NO&^C:GJ7P_OGAD$4]AXFE%Q%*883'_E?_
M  9^+WQ!_9_^+7PV^.'PHUZ3PO\ $KX2^-O#?Q!\#:_';6MZNF>)O"NJVVL:
M3<7&GW\-QI^J6)NK6.+4-)U*VNM-U6PDN=.U&UN;*YG@D_;C_@I?_P '%7[8
M'_!2W]G_ $S]FKQ?X#^%/P9^&-_J'A[7OBA9?#.+Q3=7_P 3M<\,:BNL:+:7
MU[XJUS5SHG@O3M<M=)\0VGAFT2[U(Z_HVGWM_P"*-0M8(K",32BT^M_T_P"'
M _G\K^C_ /X*<^./%7Q"_P""&W_! O7O&-S>W6KV&E?MJ>![.6_<R3KX5^&/
MQ0\*?#;P+;1L8H<65GX)\)^'K334V,(M.@M8Q+<!//D_#W]E[]F7XP_MB_'G
MX;?LW_ ?PQ+XK^)WQ1U^'0]!L29HM-TVW6.2\UGQ-XCOX+>Z;2/"GA71K:^\
M0>)]8:WG73-%TZ]NQ!/)''!+_6A_P=(_LW>%_P!C_P#8H_X([_LP^#KO^T]"
M^"'ACXX> $UMK&+39O$VJ:-X7^ R>(O%MWI\$DL-G?\ B[Q$^J^)M1MXI94B
MOM5N%660#>R2TD^EK?B@/X]OA#X+M/B1\6?A?\.[^]N-.L?'OQ$\%>"[W4+1
M(I+NPM/%/B73-#N;VUCF!ADN+6&^>>!)08FE15D!4FM3QQX2^)7[,_QS\7>!
M=8GOO!?Q@_9_^*^O>%-3NM'OI+?4O"OQ(^%?BZZTF[N=)U.V:.6&\T3Q-H4D
MVGZA;,CI-;0W,+*0I&_^RU_R<Y^SG_V7?X0_^K!\/5^ZW_!U%^RE+^SY_P %
M1_%/Q3TC3%L_ W[6?@'PI\9M*DL=,-CI%KXVTJS7X=?$W1X[@ 1W^NW>N>$[
M+XC^(9ES)Y_Q+M)9COGHM[M_-I_A;^O,#\:_VWOVLOB+^W[^UM\6_P!J/Q]I
MD-OXV^,WB32)8O#>B)-=6^E:=HGA_1/!/@_PSI,:Q^?<C3?#N@:-I<1$;7%[
M<1-/();FXD=_,_VDO@CKW[-?Q\^+O[/OBJYM[SQ7\%_'OB'X9^*[JRD6:QF\
M4>#K^70_$;Z?*JKYFG?VU9WPT]V!=K,0&1W<L[?I?_P;^_LI7'[6_P#P59_9
M=\,76G3WW@OX0^*?^&D/B)-';P7=K9>'?@G+:>*= BU:UN08KC1O$OQ,7P!X
M(U*%TD5[?Q2P:-TW _/'_!7C_E*7_P %#/\ L\7]H/\ ]69XBI>?=O\ 3_,#
M^BG_ (,Q/^3FOVT?^R$^ /\ U8$]?Q@U_9]_P9B?\G-?MH_]D)\ ?^K GK^,
M&J?PQ_[>_,#]'OV-O^"M_P#P4)_X)^_#[Q+\+/V1?V@?^%2> _%_C*X\?^(M
M"_X53\$?'O\ :'BZZT31?#L^K?VI\3?AMXSUFT\S1O#VCV?V"QU&VTQ?L?VA
M+);JXNIY_P"K3_@W#_X+$?\ !1O]O7]OCQ=\%?VL/VBO^%K?#/2_V:OB%X_L
M?#7_  J/X%>!O(\7:'XZ^%>C:7JW]L_#;X8^#O$$OV73?$FM6WV";59-,G^V
M^=<64T]O:2P?SM_\$T?^"R/_  [F^#WC?X2?\,6_LX?M*?\ "9_$N\^(O_"7
M_&33?MOB#1/M?A?PQX9_X1O39/['U';HT/\ PC7]J1IYR?Z;J=ZWEC.YOU$\
M'_\ !VCXW^'NJR:[X!_X)J_L>^!];ELYM.EUCP>^K^&M5ET^XE@GGL)-0T70
M[*[>SFFM;:::U:8P22V\$CHSPQE7%I6]YKRL^_Z@>F?\'G?_ "<U^Q=_V0GQ
M_P#^K @K^,ZTTS4K^'4KFQT^]O;?1[)=3U>>TM)[F'2M->_L=*34-2EAC=+&
MR?5-3TW35N[IHH&O]1L;,2&XN[>.3^QO_@\<U%]8^/W["FK21K#)JG[.?B[4
M9(4)9(GO?&EE<M&C-\S*C2E5+<D $\U^=_\ P;'_  T\!_&7_@IE+\)_BCX7
MTKQM\.?B-^S#^T/X-\;>$M;B>;2_$'AKQ!X7LM.U;3+L120SQI<VD\BI<VL]
MO>VDWEW5E<V]W##/&I:R];?BD!^.W[,W[57Q@_9.\3^/O$GPDU[^SH_BK\&_
MBE\ _B5H%V;B70O&GPP^+OA+4/"GB;0M:LK>XMOM#V#7EEXH\.7#NPTGQ=H&
M@ZN8;J.REL[GYPK]:_\ @LE_P2U\>?\ !+#]J_6/A?<+KGB'X#?$(ZIXQ_9O
M^)VJ0(Y\5^!4O(DO/"VN:C:00:9+\0_AQ<7MEH/C2UMH;"2\BN/#_C*+1M'T
M7QGHEFOY*5+NM'T _P!@7_@A7_RB)_8)_P"R$:1_Z>M;K^:[_@];_P"<:/\
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KGP_I]OI6AZ#HFEV4<-IIVE:3IMK;6-A96T4<%M;010Q(J( "BA)+9 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logo_momentus3x1.jpg
<TEXT>
begin 644 logo_momentus3x1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M]L;_ ,2<^-?_ ,V]'_#Q/_@H'_T?3^V-_P").?&O_P";>OCFB@#[&_X>)_\
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MM8UCPMX+;4[A[?X;_"71VTU-7UD3ZFVH^)KS3X?$'C75[FUT?PQH_A7\I?\
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M4,#&5;*,HFO;2EF&8>PJY9_5A_P;'_\ -[?_ ';;_P"]\K^K"OY3_P#@V/\
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M-?:MJ]_+:Z5H^FV]SJ6J7EG86MQ<Q_V)_P#!.3_@AG\-_@&FA?%W]J^T\/\
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MJ&KWPAA%U>2B*,)ZN[*BL[LJ(BEG=R%554$LS,2 JJ 222  "2<5_/C_ ,%
M_P#@NY\*_@8-:^%_[)YT'XU?%F)6LM0^(33'4/@_X'N6=UG%G>:?<PO\1]>M
M8T'EV^B7EOX3LI[JWFN_$6K76GZGX8?R$L9FE54Z4')*SY8Z4Z:>G/4D].^L
MM7JH+6Q_@]XC^+WTA_IQ\;PR;!8+%?ZO8/$K$97P7DU:MAN#^%L+.4J=+->(
M<PK>RI8[,(4O:*><9K?$5:DL1ALCP.$IXB.6O^@T21F1H@Z&5$21XPRF1(Y6
MD6-V3.Y4D:&548@*[12!22C8?7\TG_!OK\:_BM^T#X\_;Q^)OQF\=^(/B'XX
MUN3]F\WFN>(+SSWAM_._:!GATO2;&%8=-T'0K)[B8:9H&B6>GZ+I<4A@TZPM
MH<1C^ENL,9A98/$U,-.2G*FJ?-**:BW.E"HTKZM1Y^5-V;M>RO9?SAXL^'6,
M\)^/L[X S#,<-FV.R&AD<L9CL'2JT<)4Q.;\/95GE:EAHUG[:='"SS*6$IUZ
ML:4\3"@L1+#X9U7AZ91117*?G(4444 %%%% !1110!_A+T445S@%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?=G_!/K_@G7^TM_P %
M*?CE8?!+]G3PI]M-K]AU+XB?$76_.LOA]\*/"5U>I9S>*/&>M+&^P?Z\Z/X=
MTR.]\3>)I[6YMM!TJ]-K>R6@!X-^S=^S5\</VNOC'X0^ ?[.WP]UKXF_%7QQ
M=O;:%X:T86T*I!;QF?4-8UK5M1N+/1O#OAW1[57O=:\1:]?Z?HVDV:-<7U[!
M'@G_ $I_^"<'_!*C]C+_ ((-_ '4OVF_VE?&?A+QA^TE<:.EKX[^.&H:<U[9
M>%[S58+R(?"C]F[0;O3T\210ZE:RRZ9J6JQ6J^,_B%]GU#5M8A\->$DC\*>&
M^W^$7P?_ .">_P#P;A?LG+I6D ?$+X_>/M-677O$=U#I%M\;_P!HWQG90,_E
MJ(EOC\./@OX<U%FBTS34>^\-^"-/E#W5QX]^)NM7NH^,OY=/VROVW?CI^W%\
M2W^(/QBUY5T[31<6G@?X>Z&US:^"/ .CSR!Y+/0=,EFF:;4;TI%)K?B/4I+K
M7-:EAMHKJ\73=/TC3=.]/!8"==J<[QI)ZRMK*W2%]WT<METNTT_[D^B7]";C
M/Z1>/P_$N>O&\(^$N$Q7+CN))45#,N))8>IRXG*N$*&(A*G7J*498?%9Y7I5
M<KRRK[6,89ECL-5RU_4'_!23_@JM\6?V[_$EUX4T0:I\-?V<-%U)W\+?#2"^
M*:EXI^RSJ]CXI^*5Q87$EGK&O2-#'>V'AZWENO#GA!F2UTV76-3@N_%.K_E#
M15NPL+[5;ZRTO2[*[U+4M2N[>PT[3K"VFO+Z_OKR9+>TLK*TMTDN+J[NKB2.
M"WMH(Y)IYI$BB1G95/T5.G"E!0A%1C'HOQ;>[;ZMZOJ?]$O 'A[P5X4<)9;P
M9P+D>!X;X9R:BU1PF&5G.IRIXG,,QQ=64L1C\PQ3A[7&YCC:U;%8B:YZU5J,
M4JE?HM^PA_P3+_:'_;P\01W'@W3#X'^#VFZE%9>+?C5XIL+C_A&=/*N3>:9X
M5L!):77COQ3! CL=%T>XAL=/GDL8_%&N^&K?4["ZG_67_@G/_P $$]7\6)H?
MQB_;DL=2\->&IHK35/#W[/=K=W.E^*M:BG"SP3_%35;&:"_\(6)@*,_@O2+F
MV\7M+/Y6OZGX3N]-O-#U'^L7PYX;\+>!/#6E>%_">A:%X0\(^&-,ATW1= T'
M3K'0O#^@Z181;(++3M-L(K;3]-L+2%<1P6\,,$**2%49->=BLQC"\*#4Y[.>
M\(_X>DW_ .2I_P VQ_G!]*K]H_P]P*\QX$\!ZN7\7<90=7!YCQQ*,,=PEPY6
MO[.<,E@G*AQ3FU'WG&O&4N'L)65%U*F=-8K+Z/RM^QK^PG^S[^PYX$/A'X-^
M& VO:K!;CQK\3/$"VM_X_P#'-U!\R'6=9CMX%M=(M9-S:7X9TB&PT#3&:6YB
ML9-4O-2U*^ZG]JC]L;]G[]C7P(_CSX[>.+3P_'=17G_",>$M/$>J>._'-]91
MHTFF>#_"\<\5UJ4JRS6MO=ZG=26'AS19+VSE\0ZWI%I<)<U^0/\ P4#_ ."\
M/PQ^"XUOX6_LBG0OC)\4XUFT_4OB=+(=0^$?@BZ+M%*=%FM)HS\2]=MHT9X6
MTJZ@\%6<\]E<RZYXC>TU3PU7\B'Q<^,?Q1^/7CS6OB;\8O'/B#XA>.M?E,FH
M^(?$5X;FX$0DED@T[3K:-8K#1=%L/.DBTK0=&M+#1=)MB+33+"TM42%=L#DF
M(QDEB,9*=*E)J5I?QZJTM9/^'%K:4E>R7+#E:DOX9\+OHI^)WCIGU;Q,\<\[
MS_+<!G>(CF.+K9O6J5N-^*%-1]G*%/&QJ+(LM=)1I8:MC:'M*>%IT:.6Y2L#
M/#XJE^F/[?7_  6*_:&_;+DUKP'X5GN_@I^S]=226J_#WPWJ<A\0^,M/"20;
M_B7XLMDM;G68+Y99I9O"&F)I_A&&-[6VU&R\1W^EV^OS?D'117V%##T<-35*
MA3C3@ND5JWMS2D[RE)]92;D^K/\ 4C@O@7A+P\R/#\.<&9%@<ARC#)-8?!TW
M[7$UN6,)8K'XNJZF+S#&U(QBJN,QM:OB:BC&,JKC&*7]5G_!LG_S>U_W;;_[
MWNOZK*_E3_X-D_\ F]K_ +MM_P#>]U_597P>>?\ (TQ7_<#_ -1J)_BC],O_
M )22\1_^[/\ _6"X7"BBBO)/YA"BBB@ HHHH **** /\)>BBBN< HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBOZ3/^"(G_!OO\4O^"D.J:3\
M?OC^GB3X0_L2Z5J$GE:_ JZ5X[^/E[IT]S;7V@_"H7]I=1V'A'3-0M6L/%GQ
M,OK*;34NUN?#/@Z'7/$%IXDN_!32;=D!\>_\$CO^",_[17_!5CXFNGA>&Z^&
MO[-O@K6;2R^+O[06L:8\^C:3*4AO9O!?@&PFDME\;_$F[TZ6*Y&CV<Z:7X8L
MKS3]6\8ZEI-OJGA^TU[^Z+XO?M-_L2?\$)OV=M-_8N_8I\$^']?^,^F:9!J%
M[H5Q-#J]Y'XKU;3K*&X^+/[2_B[2ETN[U_Q[XBLK>TU*#PM9MINI2:+#H.EZ
M7IW@#X<KX.CB\&_;A_X*N?!?]COX7Z;^PK_P3 T#P;X1T;X>Z5<^"[OXA^![
M2T/@3X:Z>K7#ZAH_PM\MKF+Q=X[U+5;R_P!3\3_$O4[C4;>'6IM1U1;CQ=XO
MUV]U_P -?RQ:IJFIZWJ6H:SK6HWVKZQJU[=:EJNJZI=W%_J6IZC?3O<WM_J%
M]=R2W5[>WES+)<75U<RR3W$\CRRR/([,?:P67.5JM=-1>JALY><NL8^6CEOH
MK7_UG^AW^SRQ_&?]E>)OCSE^,RCA&7L<?P]X?5U5P6<<3T[QJT,=Q*DX8K)\
M@JQ2='+%[#-LVA)5JL\OR]47FO?_ !A^,GQ/^/WQ#\1_%7XP>,]9\>>/?%5X
M]YJ^O:U.))-I9C;Z=IMG"D.GZ+H>FQ,+31M T>UL=&T:PCAL-+L;2SABA3S*
MBOVJ_P""<_\ P1E^,7[8K:/\3_BP^L_!;]G.9K*^M=?GL8XO'OQ.T^21)I(?
MASI&IPR0Z?I%U9!A'\0=?LKG1$DN[.?P_HOC-(=5M].]F=2E0AS3<80BK))6
M](QBMWV26WDC_8WCSQ#\,_ G@?\ M[B_-LFX*X0R/#4,ORW"4:-/#QFL/15/
M!9)P[DF!I^VQF(5&DH87+,LPLW2P]*=5TZ6$H5:M+\YOV7_V2_CM^V'\1K7X
M:? GP5=^)M5#6DWB'7;ECIW@_P #Z1=3/$=?\:>(Y8WM-&TR)(;F6&!5NM9U
ME[6;3_#FDZUJ[0:=-_;+_P $\?\ @D?\"_V'K#2_'&N16'Q;_:+>S9K_ .)V
ML::G]F>#I[RW:&]TOX6Z+=B;_A'K=;>6;3;CQ5<%_%FMVLU^'N=%T?5IO#-M
M]^? ?]GWX+?LL?#2P^&7P7\%Z)\/_!&BI)>W26HS>:K?""-+[Q'XJUZ]>34=
M>UJXAMXQ>:SK-Y<7"VMO;VD<D&GV=K;0?B!_P4$_X+S?#CX1+K?PL_8\;1/B
MY\2TCN-/U+XM3G[?\*?!5WYK02GPVL3(/B7K=O&DLMO=V<\/@:UFFTZ\_M3Q
M;''J>@)Y?/B\SJ>PPE.2IZ<W1*+^U6G\,8[^ZG[VR4W9'^)OC%]*;QT^F9G^
M.\,/!7(\VX6\-*D_8YC0I5UA,?FN75)3I?7N/N(*$WA<LRJO3C.<>&L#7J4,
M0_:86K/B+$PPRI_L7^U1^V1^SY^QKX%D\=?'7QU9Z MS#=GPUX0T[RM4\>^.
M+VT0%M.\(>%HYXKO49/.DM[:YU2Z>P\.:/+=VLGB#6](M)EN:_B__;__ ."P
M7[0/[:4NK^ _#4MW\%_V?)Y7MT^'/AW4Y&USQI8H&1)_B=XHMUM9]<BN2TEP
M?".G1V/A&UW6D5]9>(=3TJU\0R_F=\5_BY\3/CGXZUSXF?%WQMK_ ,0/'7B*
MX-QJOB+Q'>M>7<B[G:"RLX@([/2M(L%<V^E:'I-M9:/I%FL=CI=C:6<44">=
M5]-EV28?!\M6K:OB%9J<E^[IO1_NXOJGM4DN;1.*A=I_N_@1]$#@?PG^I\0<
M1?5^-..Z2IUH9CB\/_PBY'B%:?\ P@Y;74E+$4:EE3SC'QGC;TX5L%1RISJT
M9%%%?KW^Q%_P1F_:C_:Z_L?QCXFTZ7X"_!2_6WO$\?>/-(NAX@\2Z9/$EQ%<
M> ? <LNGZMKUO=P36\]EKVKW'A[PK>6<SW6EZWJTUN]A)ZE?$4,-!U*]6%*"
MZR>K?:,5>4I?W8IM]C^D^,N.N$/#W)JW$'&>?Y=P_E5'F2Q&.K<M3$U8Q<OJ
M^!PE-5,9F&+E%-PPF!H8C$S2;C2:3:_)G0M!USQ1K.F>'?#.C:KXB\0:W>V^
MFZ-H6A:=>:OK.KZC=R+#:V&F:7I\-Q>W][<RLL5O:VL$L\TC*D<;,0*_HI_8
M@_X-^OB?\21I'Q _;#UB^^#_ (*F%O?6WPJ\.S6-U\5==MG7SHX_$6HNE_H?
MP^M9D>!I+-HM?\4[/MFG:AI?A74(X[I?Z-?V/?\ @G;^R[^Q+H\<?PA\#QWO
MCF>R-GKOQ;\9&UU[XD:VDH'VF!=:-K;6WAW2KD+$LVA>$[#0M'N1;V\U_:7M
M]&U[)]RU\GCN(JE3FIX*+I0V]M-)U9?X(ZQII]&^:5K-<CT/\Q/&?Z>.?YY]
M;R'PAP=7AG*I<]&IQ9F=*C5XBQD'>,I99@6Z^#R6E./-R5ZSQN8N$J=6D\KQ
M$'%>,? K]G?X*?LT>";;X>? OX<>&_ASX5@,<MQ::':,;_6;R.,0C5/$FNWL
MEUKOB?6#"%A;5O$&I:EJ)@2.#[2((HHT]GHHKYN4I3DY3E*<I.\I2;E)ONVV
MVWYMG^?689AC\VQN)S+-,=C,RS'&UIXC&8_'XFMC,;BZ\W>=;$XK$3J5Z]6;
MUE4JSE.3W;"BBBI.,**** "BBB@ HHHH _PEZ***YP"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HK4T30]:\3:SI/ASPWI&J>(/$.OZE8Z-H6@Z)I]W
MJVLZUK&IW,5EINE:3I=A#<7VHZEJ%Y-#:6-C9P375W<RQ00122R(A_NO_P""
M7/\ P0_^ ?\ P33^&>F_\%&_^"OLWA^'XCZ!/INK_!7]FZ_EL?$VG^!?$AVZ
MAX?O?$6@V;7$'Q,^.MU<6WVCPQX+TZXOO!?PSL+>]\7>*;O4-;M#J?PLJ$)3
MDHQ3;;222NVWLDNK?1'I9/DV;<0YKE^19#EN.SC.<VQ=# 99E6686MC<PS#&
MXF:IT,+A,)AX5*U>O5J2484Z<)2DWHCY5_X(J_\ !NQI?C7PKIG[>O\ P5%M
MXOAA^S7X?TN#QYX!^"7C/4H?"ES\0]#@@LM7LOB)\:+Z[E@E\(?".2TD=M*\
M'33Z5XJ\=RB+4M7DT3P2EC9_$/[H_P""E7_!9#4?C5H]_P#LR?L<1R_"K]F#
M2=)@\%WVO:)I0\(:_P#$?PWI4*Z;!X?T'2[:*RE^'_PG;3[:VT^R\,6EII>M
MZWH,8T[Q'%I6BZAJ/@U?DG_@HW_P5#^+_P"WMXLDT93??#S]GSP]J;W'@GX3
MV=^6;49H<1V_BWXBW=JR0>(_%<R!I+&TVOHGA"VN)-.T))[R;6?$.O\ Y>5]
M%@LOC1M4K)2J:-1W4'O=]')=/LQ>JN[27^\?T.OV?64^&JRKQ+\:L'@L^\08
MJAC\CX0J*ACLBX)Q"<:U#%8^2=7#9WQ/AFH2IU(.>59-B8RG@GF&,I83,\.5
MV?P\^'7COXL^,] ^'GPS\):]XY\;^*+U=/T'PQX:TZXU35]2N2CRR>5;6R.8
M[:UMXYKR_O9S%9:=8P7-_?W%M9VT\\?V5^PQ_P $XOVA?V\/%:VOP[TA?"_P
MQTG4X;+QM\9?%%I=1^#O#BJ(I[W3])2,1S^,/%R64J2VGA;1I5*S7.G-XAU3
MPUI%\NLQ?V\?L7?L!_LY_L#^ I=/^'&D6]WXONM)/_"Q/C/XL6S/C'Q2D&R^
MOA<ZBP6U\,>$;66WCFL_"^D-:Z19P65K>:M)K&N1WNO7O1B<;3P]XK]Y5_D3
M^&ZNG-].FB]YZ;)W/W#Z4/TW_#GZ/5#%<.Y8Z''/BG.ER87A#+\4OJF25:T.
M:AB^+LPHJHLNII.%:GD]#VF=8Z$J"5' X/%1S2E^6O\ P3E_X(2^!O@^FA_&
M#]LFQT/XF?%-8[74M$^#ZR0:S\-/ %TWDW,;>*V4/8?$;Q58[?LL]FYNOA_I
MT[7RVUOXO=-)\0VG[%_M6?MF_L\_L6>!!XT^./C2UT+[5;WB^$O!.D)%J?CS
MQO=V$*L^F^$?#$<T$UTJ2/:VMSJ]]+IGAC1IKRR&NZWI4-U#*WX[_M_?\%Z_
MAO\ "A->^%W['0T?XM_$B,7.F7_Q=NMM]\)_"-R'\B6?PLL,@/Q,U:W59VM+
MVVFMO T,[6&H1:GXPM%O=%;^1[XK_%SXF?'/QUKGQ,^+OC;7_B!XZ\17!N-5
M\1>([UKR[D7<[065G$!'9Z5I%@KFWTK0])MK+1](LUCL=+L;2SBB@1X/)\5C
MYK$8Z4Z-%ZQI[5)1[1B[JE!]Y+F>ZBTU(_S:R?P2\<OI7\54?%'Z2'$&:Y)P
M_-RJ9-PU"F\#CX996E"I#+N'LBJ^UPW"63S48>TQ>.HU\YS!THXG$T,96Q"S
M8_23]OW_ (*\_M"?ML3:KX(T>:X^#G[/TLRQP?##PWJ<DFI>*[:'=Y=S\3/%
M$$5E<^)?.E9KD>&;6'3_  A9E-/\[2M7U;2H?$,_Y+45Z]\$O@'\9/VCO'%C
M\./@?\._$OQ'\87WEN=,\/V7F6^F6<EQ%:G5O$.L7+VVB^&-"AN)X(;K7O$6
MHZ9HUH\T2W-]$9$#?64J.'P='DIQA0HP5V[J*5EK*<Y.[>FLYMM]6?Z!\.<+
M\#>%7"W]F9!@,FX0X7RBC/$XFK*I2P>&IQA"*K9CFV98NHJF(Q$H0B\3F.8X
MFK7FHQ]K7:C%+R&OM7]D3_@GY^U!^VQK@LO@OX"G_P"$2M;W['X@^*GBQKCP
M_P##/PY(C6XN8KOQ'):W#ZQJEJEW;33^'/"ECX@\3);3QWK:.MB)+J/^C#]A
M_P#X-]?A[X%&D?$']L[6K3XH>+$$%];?!SPI?7UG\-]%G*R2)#XN\0Q#3]=\
M<7ML[6DDNG:8= \,0WEM=V-ZWC71KE9&_HY\.>&_#O@[0M*\+>$= T7PMX9T
M&RATW0_#OAS2K'0]"T;3K9=EO8:5I&F06NGZ=90)\L-K9V\,$2_*D:CBO!Q_
M$-*E>G@HJM/5.M)-4HO^XM)5&M=?=ALTYIG\3^,_T\.'<@^MY#X1X.CQ3FT.
M>C4XJS&G6I<-8.:O&4LMPG-0QN=U:<E)1K3>"RU25.M1JYGAY.#_ "*_8@_X
M(K_LO_LG?V/XU\<V4'[0/QKL6M[V/QAXWTFW'@[PMJ4+R2QR^!?A_++?Z99W
M-JYM9+?Q!XEG\1^(;;4+&/5-"O/#7GR6"?L?17YY_M@_\%0OV0/V*X;[2_B;
M\0X_$OQ*MH\P?![X;BS\5_$,RLMM)&FM6:7MIHW@R.2WNX;V&7QKK/A]K^Q$
MTVC0ZK-&+9_F4L?FF(48QKXS$3VA"+FTKZVC%<M."W;M&$=VUJS_ #6SSB'Q
M(\9>*/KF<8W/N-N),6Y*C24*F)^JT'-.5+!8'#0A@LIRZE*2G.EA:&$P-"\J
MLU"\YO\ 0ROSS_;!_P""H7[('[%<-]I?Q-^(<?B7XE6T>8/@]\-Q9^*_B&96
M6VDC36K-+VTT;P9');W<-[#+XUUGP^U_8B:;1H=5FC%L_P#*)^V/_P %VOVN
M?VD_[3\*_"N\_P"&9?A==[X/[+^'NKW-Q\2=7M&^SMMU_P"*7V?3=6L\RP2L
MMOX'T_P;&UG=SZ7J\NO0#SI/Q*FFFN)I;BXEDGGGD>:>>9VEFFFE8O)++(Y9
MY))'9G=W8L[$LQ))-?;Y5P+4GRU<VK>RCH_JF'DI5'Y5:^L(=G&DJET]*L6?
MT1P#]%+&XCV&8>(69?4*3Y:G^K^3U:=;&2V?L\?FEJF%P^J<:E+ 0QCG"5Z>
M.H5%I_?A_P $K/\ @I?XV_X*,>+_ -J.]UGX=>&_AGX&^$W_  IJ+X?>']-U
M'4-?\2%/' ^*8U^Y\6^);E=/T_5KB63P;I3Z=#I/AO0K?3(7N+:4ZI*WVYOV
M,K^3_P#X-@?^;X/^[:?_ 'O]?U@5\OQ)A</@LZQF%PM-4J%%854Z:<FHJ6#P
M\Y.\G*3<IRE*3DVW)MMW9^$^-F091POXF\1Y#D6"AE^4Y=3R*GA,)3G5J1I1
MJ\.91B*K=2O4JUJE2K7K5:U6I5J3J5*M2<Y2;DV%%%%>&?E84444 %%%% !1
M110!_A+T445S@%%%% !1110 4444 %%%% !1110 4444 %>H_!7X*?%?]HSX
MJ>"/@C\#O FO_$OXJ_$;6H?#_@WP5X9M5N=4UC49(I;F9R\TD%EINEZ986]W
MJ^O:]JUW8:%X=T.PU'7=>U'3M'TZ^OK?V3]BG]B+]HK_ (* _'CPW^SS^S3X
M)F\6^--: U'7-7O))-/\&_#OP?;WEI::S\0/B'XB%O<Q>'?"&A->VPNKD07F
MJZK?W-AX=\,:3KWBK6-%T+4?[AO!EE^Q;_P;M_"+5O@U^SE%X>_:0_X*2>/_
M  O;:?\ &7XVZS:V=U8?#_[5%8W4WAZ?[*QG\+>$8=9LH-:T#X.:??GQ#KC6
MFE>*?BEKGE6_@R.\VHT*E>:A3BVWOV2ZMO9)=6_+JTG^@^&/A;QSXP\79=P1
MX?9#BL^S[,'SN%)>SP>78*$H1Q&:9OCIVPV6Y9A.>'M\9B9PASSI8>BJV*KX
M>A5S_P!C7]@S]CG_ (-X_A9HG[2O[6T^@?M"_P#!2+QMH%\_P]\">&;VUOM,
M^&$-[:ZCIUWIOPVFU'34F\/VU];W<FB?$/XY:[ID]]/:#4/"OPXT1K27Q#8>
M-?R%_:Y_;)^.?[:WQ-F^)GQL\2)?2VJ7-GX2\'Z-'/I_@KP%HMQ/YYT;PKHL
MEQ=-;I(RPF_U6_N=0U[67M[:36-5OFM;40>+_%3XK?$;XW^/_$WQ2^+'B_6O
M'7C[Q?J#ZEK_ (EUZY^T7EW,56*WMH(T6.TTW2M-M(X-.T71-,M[/1]#TFUL
M])T>QLM-L[6UB[S]G']F'XW_ +6/Q%L?A?\  KP+J?C/Q)<!;G4KF$+9^'O"
MVD[BLVO^+O$5T8]*\/:-!AD6YO[A)M0NS#I6D6^HZS>6.G7/TF&PE+!P<Y-.
M:7OU):**TNHWT2\WJ_)6BO\ H>^C7]$WPO\ HF<*XKC3BG,\ES'CJCE=3$\6
M>(^=SH8#*.',%[)O&X#AZKF,J<,ER:E&4J6*S.O*CF6<:U,;+#X6>'RK!^#0
MPRW$L5O;Q23SSR)###"C2RS2RL$CBBC0,\DDCLJ(B*6=B%4$D"OZ5/\ @G/_
M ,$&?%/Q'&B?&#]MJRUSP%X%9K/4M"^!$4MUH?Q \6P"2*Y!^(MY$8=2^'^@
MW4*BUG\.636GC^Z2XNA<7G@:ZL;:34OUY_X)Y_\ !(3X&?L.6%A\4OB)<Z-\
M5OVA++3GO;_XAZQ;+#X-^&S& S:E%\-M+U1473C:0A[6Y\?:U&GB:\LXKJ2Q
MC\):9JVJ:"_RI_P4$_X+U> /A6-<^%?[&AT3XJ_$2-;K3=4^,=VJ:E\*_"-Q
MN:WD?P=%#,J_$G6[;;--:ZFCQ^ ;:8Z;>Q7?C>T?4-'ACVV)QU1X? 0D_P">
ML[QC%=^9JT%OJ_?>T(\UK_S'XQ?35\2/''/<?X2?1 RS,88%-X7B'Q=KTJF7
M2HX6I*5.I7R2KBZ<5PUETH1J^RSK'0_UBQSYX9#EF!Q="AB<5^L7[0/[4G[)
M'_!.;X0:+#XTOO#7PX\,Z3ID]C\-O@U\/=)TF'Q/XABLS)-)IO@7P'I\NFP)
M:"[E(U#7+Y](\,:?J%]"VO:[8W&HPO<?QN?M]?\ !7#]H?\ ;<N=3\&V=S/\
M'_@"\X2U^%7A75+DW/B>VAD,D%S\3O$D2V=QXOG:;;<)H4=MIWA"QDM].E30
MKO6-.&OW7YQ?%'XK?$CXU^-];^)'Q9\:^(?B!XY\17!N-7\2>)M1FU'4)]N1
M;VD!D/DZ?I=A$5M=*T?3H;32=(L8X;#2[*TLH(;>/S^O?R_):&#M5JVQ&)WY
MY*\(2W?LXOK?_EY*\M+I0NT5X(?1,X.\,*U+BGBBM'CSQ&JU7CL1G^:4YU\#
MEF85INO6K9+A,6ZDYXSV\G.6>9@ZN9UJB>(PZRWVU;#LK7T#0->\5:UI7AKP
MOHFK^)/$>NWUMI>B:!H&FWFL:UK&IWDJPV>G:5I6G0W%]J%]=3.D-M:6D$UQ
M/*RQQ1L[ ']:_P!B/_@B_P#M2?M<1:/XV\563? +X*Z@MK>P>./'FDWA\3^*
M-*NH!<PWG@#P [V&J:U:75O+:7%GK^NW?AGPO?V-W]MT36-<DMIK$_UZ_L?_
M /!._P#9<_8ET=(O@]X%CNO&]Q9M9Z[\6O&36WB'XEZ['(Q,\#:ZUI:VOA[3
M)U$,<^A>$-.\/:)=BTM+C4+"]U&)KZ1X[.\+@^:$']8KK3V=-KDB_P#IY4U2
MMUC'FDFK-1W#QG^F!X:^%?UO*,IKPXYXQH\])Y-DN*I_V;EV(C=<N=YY&-;#
M8:5.:E&K@L##'YA3JP]EB</@U-5H_P Y/[$'_!OS\3?B.-(^('[8VLWWP@\%
MSI;W]K\)_#5S877Q5URVEA\^!/$FJ/'J.A?#ZUE$EJ\VGM#K_BPH+_2M2TSP
M?J<45VO]67P-_9Z^"G[-7@FV^'GP+^&_AKX;^$[=EFFL=!M'-]J]XB"(:GXC
MUZ^EO-?\4:P80L#:QXBU/5-3:WCAMC=^1#%&GLM?GG^V#_P5"_9 _8KAOM+^
M)OQ#C\2_$JVCS!\'OAN+/Q7\0S*RVTD::U9I>VFC>#(Y+>[AO89?&NL^'VO[
M$33:-#JLT8MG^5J8C,LYKQHPA5KR;O##8>$G"*_F<5?1=:E1OE5[R43_ "U\
M0/&#QB^D+G=/ 9AB,PS+#SK>UR[@SAO#XFCD>"49)1KRP%*=66)G0YFY9KG%
M?%U\/&<TL50P[]G']#*_//\ ;!_X*A?L@?L5PWVE_$WXAQ^)?B5;1Y@^#WPW
M%GXK^(9E9;:2--:LTO;31O!D<EO=PWL,OC76?#[7]B)IM&AU6:,6S_RB?MC_
M /!=K]KG]I/^T_"OPKO/^&9?A==[X/[+^'NKW-Q\2=7M&^SMMU_XI?9]-U:S
MS+!*RV_@?3_!L;6=W/I>KRZ] /.D_$J:::XFEN+B62>>>1YIYYG:6:::5B\D
MLLCEGDDD=F=W=BSL2S$DDU]?E7 M2?+5S:M[*.C^J8>2E4?E5KZPAV<:2J73
MTJQ9^G\ _12QN(]AF'B%F7U"D^6I_J_D]6G6QDMG[/'YI:IA</JG&I2P$,8Y
MPE>GCJ%1:?MK^V/_ ,%VOVN?VD_[3\*_"N\_X9E^%UWO@_LOX>ZO<W'Q)U>T
M;[.VW7_BE]GTW5K/,L$K+;^!]/\ !L;6=W/I>KRZ] /.D_$J:::XFEN+B62>
M>>1YIYYG:6:::5B\DLLCEGDDD=F=W=BSL2S$DDU'73>#O!7C+XB>)-,\&_#_
M ,)^)?'/B[6YGM]&\+>#]"U3Q+XBU:>.*2>2'3=%T:UO=2OI(X(I9Y$MK:5D
MACDE8!$9A^@83 X++:+IX2A2PU**O-Q23ERKXZM23<YM*]YU)2:76Q_8/#W"
MW"_!.62P7#^59?D>7TH>TQ$Z48PG55&#;Q&/QU:4L1BIP@GS8C&5ZLXP5G-1
M5ES-%?T _LL?\&]'[5OQ>&G^(OV@-=T#]FSP;<*LYTF^6W\=?%.\MWB@N;<Q
M^%=$U*W\/:%%=QR26\[>(O%UIX@T:Y0B\\(SE#"?Z5_V5?\ @DO^Q%^R1+I^
MM^"OA9!X]^(6G21W%M\4/C ]CX[\86=W!,L]M?:%!/IUCX2\):A:2*5M]4\(
M^&-"U<PLT-UJ%TI.?"S+B_*,!S0I5'CJZNO9X9ITT_[^(?[I+?\ A^UDFK.*
MNC\GXT^D=X><*>UPV QD^*\TI\T5A<CE"I@85%LL1G$_]B4&TXR>"_M"K!KW
MZ"33/RP_X-L?@Y\5_A[X4_:F\<^/?ASXR\%^$OB<OP$D^'>O>*?#VI:#8^-K
M7PY#\89]9U'PPVJ6]J^LZ391^)M#!UBQCFTN>2^$-K=S36]W'!_3O117Y1FN
M83S3'XC'SIQHRKNG^[C)R452I4Z,5S-)R;C33D[).3=DE9+_ #\X^XOK\>\7
M9QQ9B<%1RZKFT\(W@J%6=>G0IX++\)EU&/MJD82JS='!TYU9\E.,JLIN%.G!
MQA$HHHKSSX\**** "BBB@ HHHH _PEZ***YP"BBB@ HHHH **** "BBB@ HH
MHH *_3W_ ()?_P#!*+]I/_@J7\7W\$?".RA\'_"KPA=V$_QJ^/\ XHM)7\"?
M"O0KJ.XN@IB6>SF\6>-=4M;.Y3POX&TFZAN]2N_+N]<U/POX4M]8\5Z1]&?\
M$G/^"+7C_P#;ZCO_ -HCXZ>*U_9J_P""?GPUO;NX^*G[0OB*YT[1K[Q3%H<T
M46J^#?A!'KL,]AJ6NSWDL.B7WC+4K*\\)>%;Z6X@%MXL\5V,'@35?VV_:R_X
M*'>";'X26'["_P#P3M\$)^S=^PWX*TZY\-_8]$BO-,\<_&=;B61M=UGQAJUU
M<W'B"'0O$\Q:;4K'5M0O/%OC43WNI?$75KO^V&\)Z#UX7"5<3.T5:":YIO9+
M]7;9+5]TKM?T=]'/Z,7B-])+B=Y3PGA5EO#>6UZ*XIXVS&C5>29!0J<LW1@X
MN#S3.JU%N6!R7"U(UZ[<:V*K8#+U7Q]#W;XB_M>_LO?\$O\ X':K^P=_P22L
M8H=2DF^Q?';]LB\?3]8\:_$#Q-96\MAJ6H>&O$]M:VT'B'7/,FOK+3_&%E:6
M?@GP9I\M[!\)M%W:C9>+=-_!J\O+O4+NZO[^ZN+Z^OKB>\O;V\GEN;N\N[F5
MIKFZNKF9GFN+BXF=Y9YY7>665VDD9G8D[_@SP5XP^(WBG1/!'@'POK_C3QCX
MDO%T_0/"_A?2;W7->UB]:-Y?LVG:7IT-Q>74B0Q2SRB*%A#;PS7$I2&*1U_K
M:_X)Y_\ !"3P7\)[73OC=^W3'X:\8>+=/M8=>T_X*S7ECJ?PT\#1V]NM_<7?
MQ.U1G?1_'.JZ=M:*^T."6X^'=@MK>->7WC>SO+>;3?H+X;+Z22^)K96=2H]O
MN7RC'9:O7_<F>/\ HU_L\O#&EED)WSW-J,:ZP=!8;,/$?Q)S7#1=&.*K03HJ
MAEN'JU*D*52J\!P[DRJU*.&3S#%RIX[\A_\ @G5_P1Z^-7[:T^C_ !&\<'4O
M@]^S>UVLDGCF_L57Q5\0+6W<&ZLOA?HE_'LN[:5A]A?QSJT)\+:?</<MIT/B
MS4=(U/0(_P"J'Q7\1/V!_P#@CO\  ;3O#<,&D?#[3;B*:[T3P-X;CB\1?&3X
MOZ];Q2BYUF\6ZN8M6\0WLDBFUN/%7BC4=,\)>'EDL-!BU/0]/_L72%_.C]O_
M /X+T> OA;#K'PB_8F31/B)XVM8;O1;_ .,UQ;1W?PQ\&30?Z"H\!:846W^(
M>IV02>2QU>01_#^V>'3;JS_X3O3;JZL;?^2_XE_$_P"(7QD\;:[\1_BGXQU_
MQ[XY\2W7VO6_$WB74)]2U.\D55B@A$DS%+6PL;=([/3-,LX[?3=+L(;?3].M
M+6RMX((^C#97BLP<:N-<L-AKJ4*$=*L^SE=>XG_-).6_+"*?,?R!G/#_ (\?
M3)S7#<1>->+Q_A9X-4,3''<.>$V3UZE+,\QI0E?"XS.WB*5.I+%RINSS;.L(
ML5#]]_8F09/AL=]:E^CO[>O_  5Q_:-_;<EU#P=%</\ ![X#O-M@^%'A#5;M
MY?$EO%(98)OB7XG5+&Z\9S++LF31TL])\(6TEMI]RGAV;6+$:U/^4]>P?!#X
M ?&;]I'QQ9_#GX&_#KQ+\2/%]VJ3/IOA^S#VVEV+W$-H=7\1:S=R6NA^&-"B
MN;BWM[C7?$6HZ7H]M-<013WL<DT2O_5?^Q!_P;[?#CX>MH_Q"_;)URR^+/C"
M V]_:_"'PM<7UI\+M$N8Y9Y(X_%6MLEAKWQ!N(P-/GDTZWA\->%X+J+4=*U*
MV\;Z/<1W+>S5Q.7Y115-<E.RO&A27-5F^[5[W?6I5DD[6YFU8_4N*/$;P,^B
MYPMA\@IK+LCC1HNMEO!G#E*&,XBS2K*"BL7B:4JWMW4Q*II5,[X@QE&&(=)P
M>-K5HPI/^<K]D'_@GO\ M0?MM:V+7X,^!)(_!UI>/9:_\6/&#77A_P"&/AZ>
M%(7N+6Y\1?8KR;6M6@6YLVF\.^$]/\0>(H(;RVO;G2H--:2]B_KY_8@_X(O?
MLO\ [([Z1XU\76D?Q_\ C9I\D%[!XY\<Z-:Q^%_"VI6UT;JUNO /P^DGU/3-
M&OK)XK&6V\1:[>^)?$UIJ-DVHZ%JOAZ&[ETV/];?#_A[0/"6AZ3X8\*Z'H_A
MGPWH.GVNDZ%X>\/Z99:-H>BZ791+!9:;I.DZ=!;6&G:?:0(D-K9V=O#;V\2+
M'%&B*%'Y_P#[7G_!5']C;]C-M2T+XB_$>/Q;\3;"-Q_PJ'X8Q6_B_P =Q7*F
MW_T77UBN[7P[X)F\JZ@O%@\;:]X?O;NP+W.DV>IE!$WS=;,<SS>K]5P5&JHS
MNE0PT93J2C?656<5=15_>^"FD_?NM3_-_P 3OI1^,?CMCJW"G!>!S'ASAW%\
M]./#G"SQ.)SC,<*WR2GGV=T*=+$SPSC*2Q.'PT<NRE49\F.I8I4UB'^C%?GG
M^V#_ ,%0OV0/V*X;[2_B;\0X_$OQ*MH\P?![X;BS\5_$,RLMM)&FM6:7MIHW
M@R.2WNX;V&7QKK/A]K^Q$TVC0ZK-&+9_Y1/VQ_\ @NU^US^TG_:?A7X5WG_#
M,OPNN]\']E_#W5[FX^).KVC?9VVZ_P#%+[/INK6>98)66W\#Z?X-C:SNY]+U
M>77H!YTGXE3337$TMQ<2R3SSR/-//,[2S332L7DEED<L\DDCLSN[L6=B68DD
MFOI,JX%J3Y:N;5O91T?U3#R4JC\JM?6$.SC252Z>E6+#@'Z*6-Q'L,P\0LR^
MH4GRU/\ 5_)ZM.MC);/V>/S2U3"X?5.-2E@(8QSA*]/'4*BT_;7]L?\ X+M?
MM<_M)_VGX5^%=Y_PS+\+KO?!_9?P]U>YN/B3J]HWV=MNO_%+[/INK6>98)66
MW\#Z?X-C:SNY]+U>77H!YTGXE3337$TMQ<2R3SSR/-//,[2S332L7DEED<L\
MDDCLSN[L6=B68DDFFJK.RHBL[NP5$4%F9F("JJ@$LS$@  $DD #-?JU^RK_P
M1D_;C_:D&G:W'\/!\%OAW?!)QX]^-0U#PC'=V9,,GFZ!X.%C>>.M<-W:2M<Z
M1?KX>LO#&H[%1O$MHDBS#[B,,IR+#67U7+Z'5RDHRJN*ZRDW5KU+/JYSMHC^
MJ</AO#SPGR3EIK(N$,I5E*I5JTZ%;'5:<=/:5Z\YX_-<8HNT>>>*Q4HVC%-6
M1^4=?37[.G[&W[3O[66L?V3\ ?@WXP^($,-W]BU'Q):V4>E>!]#N1#]H,&O^
M.]=ETSPCHUR;8&>&QO\ 68=0O$&RQM+J9DB;^QK]E+_@@5^QQ\!3IOB+XO1Z
MG^T]X_LW@N#/X]LX]%^&5G=P2W#*^G?"[3;V]M-2MYX)H[>_L?'VO^.M-N7M
MDN;:PTYG>*OVUT'0-!\*Z+I?AOPOHFD>&_#NB64&FZ+H.@Z;9Z/HND:=:H(K
M:PTO2]/AM[&PLK:-1'!:VD$4$* )'&J@"OD\QX[P]/FIY9AY8B2T6(Q"E2H^
ML:2:K5%Y3=!IWT:W_GWC3Z6.38+VV$X&R>KG->/-"&;YQ&K@<L3Z5:& @X9C
MBZ;T7+B)Y5-._NR25_Y</V5?^#;?1;'^S/$_[8GQ=EUNY5X;J7X5?!EIK#2!
ML>&=;37_ (D:[81ZKJ$-Q&9;+5--\-^%]!GMG1I=*\8W >.9/Z+?@-^R]^SU
M^S!X=/A?X!?"+P5\,-,FM[6VU&X\/:4A\0:]'8^9]C?Q3XMU![WQ7XLN;;SI
M1#>>)=:U6\C$CA9P&(KWFBOA,PSK,\S;^N8JI.G>ZH0M3H1[6I0Y8R<>DIJ4
M^\FVS^2^,/$[CCCJI/\ UCS_ !>)PCGSPRO#R6"RFERM.'+E^&5/#U)4[)0K
MXB-?$Z7E6E)MLHHK@/B1\5_A?\'/#DOB_P"+?Q&\#?#'PK#*()/$?C_Q7H?A
M#1?M#J6CM4U+7[ZPM)+N4*1#:QRO<3M\L43L0#YL*<ZLXTZ<)U*DVHPA"+G.
M4GM&,8IRDWT23;/A:=.=6<:=*$ZE2;484Z<7.<Y/:,8Q3E)OHDFV=_17R'^S
M'^W5^S)^V/XA^*F@?LX_$"3XCK\&QX-7QKKMIX=\1:+X>2Z\<3>,8=&M-%O_
M !%IFD2Z\4_X0C6);N^TRUGTCR9;![+4KW[1((/KRM<5A,5@J\\-C,/6PN(I
MJFZE#$4IT:T%5IPJT^>E4C&<.>E4A4BI13<91>S1KBL)BL#7GAL;AZ^$Q--4
MW4P^)I3HUJ:JTX5J?/2J1C.'/2J0J14HIN,HO9H****YSG"BBB@ HHHH ***
M* /\)>BBBN< HHHH **** "BBB@ HHJ2&&6XEBM[>*2>>>1(8884:66:65@D
M<44:!GDDD=E1$12SL0J@D@4 1U_2-_P3+_X(W> KSX8Z'_P4*_X*DZIJWP>_
M8OM?LFO?"?X-1O=:7\:?VPM0C^Q:GH.C^$]"'V/6=.^%WBR"38WB.RO=(UCQ
M#H4DNN:5K'@_P3(/B?8^\?L6_P#!,#X%_P#!.SP3X*_;'_X*J^"H/B!\=O$=
MC!XM_9J_X)Q7TUE'JGE![^/2OB)^U?IVH6%_%X=\/&\MK>[TKP%?VE\(Y8GL
M?%VB>(==M?$O@#PSS_[4G[67QR_;*^)]U\3OC9XHDU[5Y/-L?#7AO3(9;#PC
MX(T2:X,MOX:\%^'Q-<KIFFPDQH\LTU]K6KS1I>Z]JNK:F\M[)Z6"R^>(:G4O
M"BNOVI^44^G=M6\G9H_O?Z(WT&^+?I XK!\8<7?7N$/"*A7YJF;^S5'.>+_8
M5'&O@.%:6(ISA#"QE"=#&<18FE4P.%J<U' T<SQ='%T<)[5^VQ^W]X]_:S?P
MW\.O#N@Z5\%?V6/A7#8:-\$_V<? L%IH_@OP=H6@Z<-#\/7.JV>DVUA8:QKV
MGZ(O]G:<19P:/X7L)[O3/"VG:;!?:M/JN)^Q)_P3Y_:$_;K\:KH?PLT Z3X$
MTJ_BMO'7Q=\1P7-OX%\&P^7'<3VQND02^(O%$EK+"VG>$M$^T:G<27=G<ZF^
MBZ"UYKMC^HW_  3S_P""&?BKXE6FG_'/]MQ=1^$7P:T^ >(;7X7WUZ?#7CWQ
MAH]C"FHSW_CB]F:"?X7^"Y+=9%OTN9;+QU=64.H/''X.A.E>(KKZK_;"_P""
MUOP4_9E\&)^S-_P3<\)^#+E?"=E=^'+;XFZ9HMI'\)? ^QY([A_ASH(C6'XB
MZ\U[+>:C-XNU=7\'WFIB/62/B-;:Q>21>W3<ZC^JY=2524=)5%I1HW^U.>TI
M:W:NVVGI)IQ/](^*/I#9%P-@Z?T=_H4<%Y+Q)GV04?[-S#B;"03\,O#IU>>&
M(S#-L[4JD.*.)74C5Q&(Y\1BUBLP56>+Q&>9E1QN33^U/"/@3_@GC_P0W^$$
M?B+Q7KBZU\7_ !1HS6MUXDNK+3M;^.GQ:NH%6XO]*\#^&8[B*+P=X$_M*W11
M;_;M+\*Z?)'HL'C/Q?K?B!;'4[W^:W]O?_@K/^T3^W#=:AX3-U)\)?@*TT7V
M+X0^%=4GE774M9_M%M>_$?Q*D%A>>-+P7"PW$6F-;:;X3L);/3KFT\.C6+23
M6;O\YOB+\2O'_P 7?&6M_$+XG^,?$/CSQMXCN3=ZUXF\4:I=:OJU[(%"0QM<
MW4DAAL[2%4M=/T^V$-AIME%!8V%M;6D$,"?JQ^Q!_P $6/VH/VL?['\:^.;*
M?]G[X*7RV]['XP\;Z3<'QCXITV9))8Y? OP_EEL-3O+:Z06LEOX@\2S^'/#U
MSI]]'JFA7GB3[/)I[^M0P.#RQ?6\=6C5Q&C=:KM&2M[M"GJW):)-)SLKQ4$W
M$_'\N\-?#_P>Q&,\:OI!<>TN-_$K'55B\7QKQA5=>GA<="*G# <%Y U6K3K8
M2"C2P"P6$KX[#8:A%95A,GP7/@X?D1X?\/:_XMUS2?#'A70]8\3>)->U"UTG
M0O#WA_3+W6=<UK5+V58++3=)TG3H+F_U'4+N=TAM;.SMYKBXE=8XHW=@I_HQ
M_8@_X-]OB/\ $)='^(7[9.N7OPF\'SBWO[7X0^%KBQN_BCK=M)'/)''XJUMD
MO]!^'UO(3I\\FG6\/B7Q1/:RZCI6I6W@C6+>.Y7^CC]D3_@GS^R[^Q/HPMO@
MQX!@/C"ZL/L&O_%;Q:\'B'XF^(H7^SFYAN?$4EK;Q:+I=Y):6DUSX=\)V'A[
MPU-<VL%Y+I#WR-=/YM^V+_P56_8]_8N74=$\>^/E\;_%*R5HT^#WPQ-EXH\;
MV]V!"5A\3N+VU\/^!E5+FWNY(O%^LZ3JMSISO=Z)I.LM']G?AK9QC<PJ_5,H
MP]:4I;2C#VE>4;V<E%*4:,%?WIR;Y5[SE3L?S3XF?33X[\0<=6X.\!>'\SRR
MCB.>B^(*F#AC>*,71O[.I6P.#@L1@>'L):4N;'8F>*QE*G*GB88C*:T))?8'
MP0^ 'P9_9N\#V?PY^!OPZ\-?#?PA:,DSZ;X?LRESJE\EO#:'5_$6LW<EUKGB
M?79;:WM[>XUWQ%J.J:Q<PV\$4][)'#$J?'_[8O\ P56_8]_8N74=$\>^/E\;
M_%*R5HT^#WPQ-EXH\;V]V!"5A\3N+VU\/^!E5+FWNY(O%^LZ3JMSISO=Z)I.
MLM']G?\ E!_;'_X+E?M@?M/?VGX7^'^J?\,U?"J\\R#_ (1GX9ZO>'QSJ]D_
MDGRO%/Q4\C3->GR4N(I;7P?9>"=)OM/NY-/UK3=81?/?\7W9G9G=F=W8L[N2
MS,S$EF9B269B22222223FO9RS@>K5DL1G.(E%R?-+#4)J=63>K5;$OFBG?22
MI*IS)WC6BS\TX0^C!G&=XR?$/BKG^+K8S&UGB\9EN%QTLPS;&5ZCYJD\XS_$
M2Q$76G)-5XX3ZY.M"7-#,J-1:?M!^V/_ ,%ROVP/VGO[3\+_  _U3_AFKX57
MGF0?\(S\,]7O#XYU>R?R3Y7BGXJ>1IFO3Y*7$4MKX/LO!.DWVGW<FGZUINL(
MOGO^+[LSLSNS.[L6=W)9F9B2S,Q)+,Q))))))))S7U]^S+^P5^UG^U[>0+\"
MO@SXI\2^'FNY+.[^(&IP)X9^&^FS6QA^W177CG7WT_P_<7UA%/%<7&B:7>:C
MX@>%U-KI-R[QQO\ TF?LK?\ !M[\,_#']F>)?VO?BC??$W6(C'<77PS^%4VH
M>%? *RHTBRV.K>-[VWM/'7B:PGB,<@DT/3_AM?VUPNS[3=0JWG?35<QX?X<I
M/#PE0H26^&PL55Q,Y1T3JV;GSVT4\34BVE92=K'[9F'&7@]X+9?+*,-5RO*Z
MM-)RR/(J4<?G6)JTXM1ECW"<Z[Q#C>,,3G>,HN27(J[LD?R6?#KX8?$?XO>*
M+/P3\*O 7C#XC^+[]));3PSX(\.:MXHUN:"$K]HNAINC6EY=)9VH=7N[V2-+
M6TB)EN9HH@7'[^?LJ?\ !NE^T-\1)=.\1?M2^,]%^ GA5I(YKCP7X<FTSQ_\
M4]0@CN8#):37&FWDW@+PHE_8O-)9ZL=<\8W]A<HD.I>$ 2ZI_7C\'/@-\&/V
M?/"L7@KX)?#'P7\,/#*&%Y]-\'Z#8Z2VI7,$*6Z:AKE]!%_:/B#5FAC2.;6-
M<N]0U2X"@W%W*>:]:KX[,>.<;7YJ>7488.F]%6J<M;$-=TFO8T[K=<M5K1QF
MC^:>-/I6<3YK[7"<&Y;A^&\'+FBLQQBIYEG,X[*=.$X?V=@G)-J5-T,?4BU&
M5+%0:=_@;]E?_@F3^QE^Q\FGZC\*/A%I6H^.[!("?BM\0FC\;_$>2\@22+^T
M-/UK5;<6'A&YN(Y"EW#X"TCPGIUT%1IK%W7?7WS17 ?$CXK_  O^#GAR7Q?\
M6_B-X&^&/A6&402>(_'_ (KT/PAHOVAU+1VJ:EK]]86DEW*%(AM8Y7N)V^6*
M)V(!^-J5<7CZZE5J8C%XBHU&/-*I6JS;VA!>])]HPBK+9)(_F;,\VSKB/,)8
MW-LPS'.LRQ$E'V^-Q&(QV*G=MQI4W5E4FH1;:IT:=H05HTX1BDCOZ*_ W]HS
M_@XG_8;^$2W^E_"&#QS^TIXJMXIEMO\ A$-*G\%> %OX)C$]GJ?C;QM:66I^
M2X4R0:IX5\%>,--G3:T5PRL&K\%OVC?^#AW]NOXQ-J&E?"J7P5^S9X3N7NXH
M(_ ND1>*/'<FFW49C%IJGCKQI!J4*7EN"7@UCP=X7\$7\4F)(W1E4C[/*/#;
MBS-N6?U#^S:$O^7^:2>%LM_]VY9XQW7POZNH/^=;KZG)_#/BW-^6?]G_ -FT
M)?\ +_-)/"V7_8-RU,:[K6+>&4'_ #K<_N<^)'Q7^%_P<\.2^+_BW\1O WPQ
M\*PRB"3Q'X_\5Z'X0T7[0ZEH[5-2U^^L+22[E"D0VL<KW$[?+%$[$ _B9^T9
M_P '$_[#?PB6_P!+^$,'CG]I3Q5;Q3+;?\(AI4_@KP M_!,8GL]3\;>-K2RU
M/R7"F2#5/"O@KQAILZ;6BN&5@U?PU?$/XG_$GXN>([CQA\5?B!XU^)7BR[1(
MKGQ-X]\4ZWXNUZ:&//E02:MK]]?WQ@A!VPP>?Y4*X2-%4 #AJ_4,H\',IP_)
M4SC'XG,:BLW0PZ^I87SA*2E4Q-1=%.%7#-[\JV7ZED_@SE&&Y*F<X_$YE45F
M\/AE]1POG"<E*KBJBOM.%;#-[N*V/WE_:-_X.'?VZ_C$VH:5\*I?!7[-GA.Y
M>[B@C\"Z1%XH\=R:;=1F,6FJ>.O&D&I0I>6X)>#6/!WA?P1?Q28DC=&52/Q3
M^(?Q/^)/Q<\1W'C#XJ_$#QK\2O%EVB17/B;Q[XIUOQ=KTT,>?*@DU;7[Z_OC
M!"#MA@\_RH5PD:*H '#5]S? O_@FC^W?^T?':7GPG_9B^)VIZ'?VJW]CXL\4
M:5;_  X\%ZA8F18S<Z7XP^(UWX5\-ZR%+$F#1]3O[MU20Q6\A1@/T3#9=PUP
MOA^>A0RO)J*7++$U94,/*:6MJN,Q$E5JV_Z>59L_1L-EW#/"V'YZ&'RK):*7
M)+$U94,-.:6MJN,Q$E5JM+7][6FS]^O^#63_ )OJ_P"[8O\ WX6OZX*_"K_@
MB9_P35^//_!/?1_V@;_XZZ[\-[_4OC;'\'Y=&T+P#K>N:]=>&Q\/X_B8VJ6_
MB6]U/PWH.F_;;B3QU916R:#=:Y9?Z#=N=0*M!O\ W5K^8./\=@\RXNS?&X#$
M4\5A*SP*I5Z3YJ=1TLMP="IR2LN91JTYPNM&XMIM6;_EOQ!Q^#S/B_.,;@,1
M3Q>$K/ *EB*+YJ=3V.68*A4Y)65U&K3G!M:-Q;3:LV4445\<?&!1110 4444
M %%%% '^$O1117. 4444 %%%% !117O_ .S)^R_\</VPOC#X;^!?[/O@;4/'
M?Q \2>?=?9;=XK+1O#F@6!B.M>,?&?B&]:'2/"7@SP[!-'<Z[XFURZM-,L(W
MAB:9[NZM+:X-]AI.348IRE)I1BDVVV[))+5MO1):MGF7P\^'GCKXM>.?"GPS
M^&7A+7_'GQ!\<ZYI_AKP?X.\+:9=:SXA\1Z]JDZV]AI>E:;9QRW%U=7$K@!4
M3;&@>:5HX8Y'7^L3]GC]F+X$?\$7](TKQW\0H? _[1O_  5AN+87VD^'XKNR
M\8_ O]@.YN;41*NI-:22Z)\3OVD],%Q=)-)%<7_AKP)KMO')I1%KHEEK_P 3
M\[X92_ G_@EEX$UWX4?L9>)[#XK?M>^+-%N/#'[07[?VF)(FG:)9ZA!;CQ'\
M'_V.(KN&*]\.> +&]@6RU'XW7%O8^-?'^H6U[KNA'2M ;P0/#?T)^P3_ ,$I
M_C/^V<W_  MCQ[J,WP4_9DTY[[6?%/QI\8Q+:S^)M-TJ2:77O^$!M]8DM8-8
M$3V]Y;ZKXWU.>'P=X?FM]4FN;W6=6TBX\-W/L87 0A%8C&/EBK.-)[R>ZNE=
MN_2"7,WOIO\ ZD?1Z^AGPIP5PSAO'[Z7N-P_!W V!>&QW#_A[F_M:.:<1XBI
M!XC +B#+J499G4^M\BGE_!6!P]7/,XE&2S.AA<#2K8#,?C_P1\/_ -J']O[X
M^ZA:^';+QE\<OC7\0+]M;\3:_J5TURUM:H;:Q?7?%.OWKPZ1X6\+:-;_ &'2
M[22[GT[1=)LX]+\/Z-;Q+_9>F-_2E\)OV4/V$?\ @B]X,T7XZ_MA^--#^,?[
M5%W:V^J>!_"NB6$>MW.C:I;(TDL/P<\#ZK)8RSR66I12P3?&7QVGA^TM)+33
MXM*7P1J5_/IFM>"_&/\ X*B?LL_L!?#:^_9>_P""6/@KP_K6O0Q/IWC3]I'7
M+&+6M/U+7[-9[.;Q';7M[;07?Q>\5QW5QJ-SIVO:I#:_"S0E-I;>#="\2>#K
MJ#2=._"CPCX"_:H_;Q^-&J#PSH_Q%_:#^,?BVX74O$6LW-Q-JMS!"=EI!J'B
M?Q/K%Q;Z%X2\.V2);Z987.MZEHWA[2X$L=(L7MHEL[0?04<#6Q4?:8EO!8&*
M3Y&U3K58*WQM^[0IVTL_>:T:LTU_5G&_%OB'X\Y16P>85,5]'+Z,^6X*-%Y+
M[;!<.\?<9\/X2$:5*'$.(C*&!\/.$986$*']A4*CQ-7!JKAL<Z^#Q.%GA?JG
M]O7_ (*N_M%_MR7M]X9O+U_A5\"5N5;3?@[X2U.Y>TU6.WN1<VE[\1?$*Q6-
MYX[U.*:.VFBM;BUT[PKI]Q965YI?AFSU6*XU2\\=_8__ ."=_P"U'^VUK"1?
M![P+):^";>\:SUWXM>,FN?#WPTT*2)29X&UTVEU=>(-4@8PQSZ%X0T[Q#K=H
M;NTN-0L++3I7OH_Z-OV(/^#?GX9?#@Z1\0/VQM9L?B_XT@>WO[7X3^&KB_M?
MA5H=S%-Y\">)-4>/3M>^(-U$8[5YK Q:!X3#F_TK4M,\8:9+%=O^A?[4W_!3
M;]A_]@30D^'^J^(]'U/QAX6T^#2-!_9_^"6G:-J&N^'[>RAMX;+2-2TW39M-
M\(_#;3[*VGM)8M/\1ZCH=\VDDW&@:+J_E"V;19BDXY?D6#EB:NR=.G*4%LI5
M++WJEOM5:CC!:2E*43^8<_\ I1<(\%8*GX5?15X$H9]B\.JE&EFN%RW%?V!A
M:MH4J^84</[F9\0XM-)XG.\WQ&%P4IPI8JKBLUPTG?S?]B'_ ((R?LN?LBMH
M_C/Q181_'OXV6#0WD?CWQWI-M_PCOAG4H98KB*?P#X!DFU#2-#N;.>WMKBR\
M0:S<>(_%EE>12W.DZYH]O=R:='Z]^V+_ ,%5OV/?V+EU'1/'OCY?&_Q2LE:-
M/@]\,39>*/&]O=@0E8?$[B]M?#_@952YM[N2+Q?K.DZK<Z<[W>B:3K+1_9W_
M )0?VQ_^"Y7[8'[3W]I^%_A_JG_#-7PJO/,@_P"$9^&>KWA\<ZO9/Y)\KQ3\
M5/(TS7I\E+B*6U\'V7@G2;[3[N33]:TW6$7SW_++X1_!'XQ?M!>+X?!'P8^&
M_C3XH^+KMHI9=*\(:'J&MSV5O<W<5I_:NN7=O$]GH6CQW-Q$M[KVN75AI%B'
M\Z^OK>(-(/5PG"%>N_KO$.-Y%%<TJ%.I#W([VJXA_N:,4])0H1E%IWC5A(_&
MX>"G&''F95..?I \<XO%XA0=:MET<PH<N"PW-[26&JY@U')\DP-.=^? 9'AO
MJO+-SHXS#U6V?J;^V/\ \%ROVP/VGO[3\+_#_5/^&:OA5>>9!_PC/PSU>\/C
MG5[)_)/E>*?BIY&F:]/DI<12VO@^R\$Z3?:?=R:?K6FZPB^>_P",UO;WFHWD
M%K:P7-_?W]S';VUM;QRW5Y>WEU*L<,$$,:R37%S<3.L<<<:O+-*ZJJL[ '^E
M[]E7_@W ^+'BTZ9XE_:Y^)FF_"C0Y!:W-S\-?AG+I_C'XB30OYRW>FZMXOG2
MX\!^%+Z$K!)!=Z+#\3;.XCDDCD6TE0&OZ2OV7O\ @GS^R-^Q[:VK_!#X.^'M
M(\50VOV:Z^)/B"-O%?Q+U R6PM;YW\8ZY]KU+28-33<]_HWAHZ%X=DD=O)T>
M",)&O=6XEX?R.D\+E5"&(DMXX5*%&4EHG6Q<U*5:5MJD5B';1R5K'H9CXW>#
MWA9@*F1^'^4X?.*]-6E2R&*P^75:T$U">8\0XF-:MF-3E:2Q=&.;2<?<E6C:
MR_C@_94_X(;?MN_M'OIVN>+_  I%^SC\.[IXWF\2_&"VO--\67-H)6BN#H?P
MMA5/&$UY$H2XME\60^"M'U*WD66QUV89%?TH?LJ_\$+/V)/V=4TS7/'/ANY_
M:3^(=HD$L_B#XMVUK<^"X+];8P7C:)\*;4R>%!IMS(QN;>T\:MX]U'3I@CVF
MM*Z!Z_9ZN&^(7Q.^&WPC\.7'C'XJ_$#P5\-?"=HZ17/B;Q[XIT3PAH,$TN1%
M!)J^OWVGV"SS$;88//\ -F;"QHS$"OC\=Q/G6:S]A2J3P\*DE&&&P,9QG-O1
M1=2/-7J.6SBI*$KM>SMH?S7QCX^>)/&TZF#I9C+(<NKMTX95PXJV$G5A)\JI
MU\=&<\RQ4JD7R5J<<12PM:\K82$9<BZ^QL;'2[*TTW3+.UT[3M/MH+*PL+&W
MAM+*RL[:)8;:TM+6W2."VMK>%$B@@AC2**)%CC154 6J_!K]HW_@X=_84^#J
MZAI7PKE\:_M)^++9+N*"+P)I$OA?P)%J5K)Y2VFJ>._&D&FS/97!!>#6/!OA
M?QO82Q@21NZLI/X+_M&?\'$_[<GQ<>_TOX0P>!OV:_"MQ+,MM_PB.E0>-O'[
M6$\)B>RU/QMXVM+W2S,A8RP:IX5\%>#]2MY-K17*L@:O5RCPWXLS?EG]0>74
M):^WS23PN^M_J[C/&.ZU4OJ_(_YT?'91X;<79RXU'E[R^C-\SQ.:S>%O=W<O
M8.,\;*_Q*7U?EE_-JF?W*?$+XG?#;X1^'+CQC\5?B!X*^&OA.T=(KGQ-X]\4
MZ)X0T&":7(B@DU?7[[3[!9YB-L,'G^;,V%C1F(%?BG^T;_P<._L*?!U=0TKX
M5R^-?VD_%ELEW%!%X$TB7POX$BU*UD\I;35/'?C2#39GLK@@O!K'@WPOXWL)
M8P)(W=64G^&/XD?%?XH?&/Q'+XO^+?Q&\<_$[Q5-$L#^(_'_ (KUWQ?K7V9&
M9H[5-2U^^O[N.TB+$06D<J6\"_+%$B@ <CI&D:MK^IV.BZ#I>HZWK.J7,5GI
MNDZ197.I:GJ-Y,VV&UL;"SBFNKNYE8A8H+>*261CA$)XK]/RGP=RG#*-7.LP
MQ&83C:4J&'2P6%22O*,YWJ8BI%:^_"IAG;5Q1^HY1X,Y1A5&MG>8XC,)17-.
MAADL#A$DKRC.HY5,14BM7SPJ89]7%6/W9_:2_P"#A_\ ;D^,DE_I7PC/@_\
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M=64G^*"63]I_]L#X@/-)_P +T_:<^*$]J-Q5/'GQB\;'3XW.Q$2-?$.M1:=
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MX9^#](G+&<*3I\_PX\4ZE&(XW@*B/7ANGA:1RT,WV6/[+\'?\&_G_!*SPI!
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M1KWC/5[2">"631?"FF:QJY2>$I9-YJ;OQ[\8_P#!T'_P1G\+)<?V5^T?XO\
M'T]O/' ;7P=\!/C;&\Q9V2:2WNO&7@;PAITT%L5W22K?;9D97LC=J<@;2W:
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MO@NYU*W2&/5K"*/5-,U_PMKAM=.N=>\&:_X<UK4-%T#4K^\T'3/\@FOZ]/\
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M>8NS\NH'ZG_\'&7_ "FA_;@_[&?X3?\ K/GPEH_X-S?^4T/[#_\ V,_Q9_\
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MS_8W]LZO_97]H_:?[._M74OLGD_;KKS?\;ZJDK**]?T _I1_X-0O^4NW@_\
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MG4[2"_TW5-+U'X]?$^SU#3M1L;J.6VO+&^M)I;:[M+B*2"XMY9(9HWC=E/\
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MZEXH\6^(+[4_$7B"\M[2QL7U/4KB/3-.TS2XK+3K5P6M^BV\P/\ &7K]TO\
M@W"\!^%?BG_P5B^#/PP\=Z3!KW@CXC_"?]JGP'XRT*Y+"VUKPKXO_9D^*_A[
MQ#I-P5(80:CI&HWEG*5(;RYFP0<5^%M?T!?\&P'_ "F@_9A_[%?]H3_UG[XE
M5,=UZK\P/QL_:8^!OB+]F3]HGXY_L[>+)A=^(O@?\6OB!\*]4U!+>>UM]7G\
M#>*-3\.IKMC#<*DO]F:[#I\6L:7*R[;C3KZUN(V>.5';Q"OZI/\ @[?_ &5?
M^%,_\%%_"_[0^BZ5<VOA3]KGX2Z-X@U'47\E+"Y^*_PACL/AOXVT[38(@IB2
MU\"P_"#6]0DD0-=:OXFO[IGDEEE:OQ=_X)6?LJQ_MJ_\%#/V3OV;]0TT:OX5
M\<_%K1-2^(VGO(\"7?PI\!177Q"^*EH;I2OV6:^^'_A;Q%86,Q;/]HW5G'&L
MLTD<,@TT[=;V_P @/U4_X+._LI1?L<_\$O?^"#_PLO--;3O&?B+X=?M>?&7X
MF+=:9_96LCQ_\:&_95^(FK:1X@MV5)7U?P1I^NZ1\.7FG43&Q\'6,3@>4 /Y
MJ:_NS_X/6@ /^":(   '[9(  P !_P ,J   <  < #I7\)E$E9V[)+[D@/\
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M:W5K<1M#<6US;S*\4\$\3O%-#*C1RQLR.K*Q!**L#Q#_ (9;_9E_Z-T^!/\
MX:+X?_\ S/5T'A?X$? _P1K5KXD\%_!KX4^$/$5BEQ'9:_X7^'?A#0-:LTN[
M>6TNTM=4TG1[2^MTNK2::UN%BG036\LL,@:.1U)10!O>-?AC\-?B2FG1?$7X
M>>!O'T>D/=2:3'XU\)Z!XJ32WO1 MZ^G)KNGWZV3W:VMLMTUL(C<"W@$I<0Q
M[<;PG\#O@KX"U=/$'@;X0?"[P9KT<$]K'K?A/X?^$_#NKQVMTH6YMDU+1])L
M[U8+A559X5F$<J@"16  HHH UO&WPM^&7Q*_LS_A8WPZ\">/_P"Q?MO]C?\
M";>$?#_BK^R?[1^R?VA_9G]NZ??_ &#[?]@L?MOV7ROM7V*T\_S/L\.SA/\
MAEO]F7_HW3X$_P#AHOA__P#,]110!Z%;?#?X=V?@QOAS:> O!=K\/7@NK5_
MEMX6T.#P8UK?7LVI7MLWA>*Q71&@O-1N+B_NH38F.XO9YKJ97GE>1O/?^&6_
MV9?^C=/@3_X:+X?_ /S/444 '_#+?[,O_1NGP)_\-%\/_P#YGJ/^&6_V9?\
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DB6%/F^2+7?"GA'2=4C7YF^5+I1\S<<G/U/111';[O_28@?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ny20070923x1_ex5-1img01.jpg
<TEXT>
begin 644 ny20070923x1_ex5-1img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C0&8 P$1  (1 0,1 ?_$ -P  0 " @(# 0$
M       *"P$)!P@"!08#! $! 0$  @,! 0            $" P<%!@D("A
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MPW7<,E#MK1MRXO7ERR24?%L&\FZ6FS$!JW1!-$A."JVO,"BU;D:BE H% H%
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M)DK<TH_2!4Q4U36Q9L!;C"'4.D "*8RKT"C_ "A[ &[+Z_8AWLC=#G?<_A'
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M2B,226(B)# J)# !1M"K1+D[OH6?95T<,.;)L3V9&BH8B*N1<IW3D"0.F)@
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MT_-8PQL]GL)[1F$FL2'Q]&S;IK<N24VR:B#:9RC+,&\8J^9/@4.NC!B4T>W
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M0F$ $W.;RZ46CJX(E*4#"'*'8 <H@;MT_ TY]-1\6E:'YBNB4>43@!N/DZ"
M\#<H\-.W4.SMH/8A'R)]-(Z1-KQ+HP=CKX=0_,^&I6!_,H11)0Z2J:J*J>@'
M36242.43% Q0$JA2B B40'[P@/A"J/S/^ ?\DW\ TFX+43,*[YMW8JY%8TAC
MN@Z:4<0 (0QS W4QVP3>&T)QT*T,<1'L *XX)N*KLO'F'RN)S#H;M#CQ /$
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MR*9A-QUT4336*0VO'F+YT1_ZU6%BX_;734VNG+Q$>S30->'^3[O#MIN!I_Y
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M@9-%/F-R)$* #II5@AQ\?\ _Y)OX!JR+GOIA()N.G%LK;JD Z2FV?$R:B9@
M2J)#:,:4Z1@,!@$BA-2B'A :XX+RK[ZX&Q*3V ]0G,6.6\4NSQCD62<9CP])
M+)E*R?V7>THY5<1Z"C<"-P-;5QHNV"I-"'333(<0$#@-;J0U$&*)BF*'X0E$
M"><'E'GT\CF$>0"F VG'AH-+PD/]%7KXY4Z8<@CAO(T7(Y7V@7!..9*1M$BK
MHUXXMD)=_P">?W%C@Z[A5F9BZ47,X>PZB2;=TL<RJ:Z*QC>>E!8=;9NK)T]-
MV]OL9W"VZO$\LX>-S.%;8N2X$+'O*+$%0(9M+6O>(04PT=):AJ44A 0$#%$Q
M1 1E$JYWRAO6VDX8@W5QY1W)X2LB&:(*N57L]DBU6_YE%OZ2<46I9,[MTIYG
M02D3()E-0 H"(A3]UJAN=8GO3=O7):-X;<>FZ[=2+>YHN8M:]MSLI%3<,5G&
M2+<&+M/#L0X-'3'K-5!PJ0LN]1(BF(<S=-0=% 42Z@KJ**N#F76,HJJLHHJJ
MHJ<ZJBBZ@"HL=1103'55XB83&$3:B(ZZB(UK<5@G]8'Y)_Z-)58\=S=_8*W'
M?2ID_BTL2L)#2[WQ/[0O!7T8(W]?;GK<7$_DB3U56-/<U!TV*;GQ[--USP=?
M_P 3XZK$C0UWI'IW3&V+>M*;K+-@WO\ 8INO>DG';]),AF%N9F1CD275!N#(
MD3!H:YDV@R: *%$5#&6 #B)= MQ$7O@.G HZ@&NH <H^'AS:@(5?W5.2[N=U
M_P#'V,\>6YL/WPWPTLV'M4[:'VZYCN 'JD2$8_?R#A;'V0)LYG246#!T[3)#
M/C<K4&YC(+*$,5(!B?5/'@YZ%N:)83UO2T;.0LHU1>QLM$/FTC&OVBY>=%RS
M?-%%6SE!4G$IR&$H@/"I18>P<.6[-!5T[71;-D"&57<+J$2113(&ISJ*G$I"
M$* <1$=*BHQ_6-[QG@79!:<_B/:]<UGYWW82*3N,2:0RZMP6#B)8BK=%6:ON
M5C%VS1_+H%54]%B&CD[@5T@%P!$PY5-49W91INF)WH/=1MAR :S=X\I([C\
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MCV5=^2+O@+ Q]:\Y>UZ77((Q-N6S;<:[DYJ8D7!N5%HR8(I^D**G'74!*'*
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M"F,[Y+] N?)LJ*K<$GOJQ^+-".L^.<B<Y?18ELS()/)4%343&E2F%MA @
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FU%ZB]!]2>K/-AZ)ZJ]6_Z!Z'YO3D\S^;TTY>%18>^J*4"@4'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Apr. 21, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001781162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Momentus Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Apr. 21, 2026 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Class A common stock, $0.00001 par value per
share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit | $ / shares</a></td>
<td class="nump">7.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 9,982,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 1,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;">&#160;</td><td style="width: 99%;">&#160;</td></tr><tr style="vertical-align: top;"> <td style="padding: 0px 0pt;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">(1)</span> </div> </td> <td style="padding: 0px 5.4pt; text-align: left;"> <div style="margin-bottom: 4pt;"> <span style="font-size: 10.0pt;">Pursuant to Rule 416(a) under the Securities Act
of 1933, as amended (the &#8220;<span style="text-decoration:underline">Securities Act</span>&#8221;), this Registration Statement
shall also cover any additional shares of the Registrant&#8217;s Class A common
stock, par value $0.00001 per share (&#8220;<span style="text-decoration:underline">Common Stock</span>&#8221;), that become
issuable by reason of any stock dividend, stock split, recapitalization, or
other similar transaction effected without receipt of consideration that
increases the number of outstanding shares of Common Stock.</span> </div> </td> </tr> </table><table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;">
   <tr style="height: 0px; font-size: 0px;"><td style="width: 1%;">&#160;</td><td style="width: 99%;">&#160;</td></tr><tr style="vertical-align: top;">
    <td style="padding: 0px 0pt;">
     <div style="margin-bottom: 4pt;">
      <span style="font-size: 10.0pt;">(2)</span>
     </div>
    </td>
    <td style="padding: 0px 5.4pt; text-align: left;">
     <div style="margin-bottom: 4pt;">
      <span style="font-size: 10.0pt;">Estimated in accordance with Rule 457(c) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $7.13 per share, which is the average of the high and low prices of Common Stock on April 16, 2026, as reported on the Nasdaq Capital Market.</span>
     </div>
    </td>
   </tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Apr. 21, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 9,982,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">1,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 1,379<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ny20070923x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ny20070923x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ny20070923x1_ex107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ny20070923x1_ex107.htm">ny20070923x1_ex107.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20070923x1_ex107.htm": {
   "dts": {
    "inline": {
     "local": [
      "ny20070923x1_ex107.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2025": 3,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 20,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20070923x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20070923x1_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20070923x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20070923x1_ex107.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20070923x1_ex107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20070923x1_ex107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001140361-26-015951-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-26-015951-xbrl.zip
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M9JK7,F"W9UA"YXX%K/D,-6W](%35HOF^I]WJ8PRED) 5.0,TDQYAAKHNT>F
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M\G]02P$"% ,4    " #CB95<O2<"@RH-  #O1@  %@              @ $
M    ;GDR,# W,#DR,W@Q7V5X,3 W+FAT;5!+!08      0 ! $0   !>#0
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>ny20070923x1_ex107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781162</identifier>
        </entity>
        <period>
            <startDate>2026-04-21</startDate>
            <endDate>2026-04-21</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781162</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-21</startDate>
            <endDate>2026-04-21</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c0" id="ixv-141">S-3</ffd:SubmissnTp>
    <ffd:FormTp contextRef="c0" id="ixv-142">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-24">Momentus Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c1" id="ixv-143">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c1" id="ixv-144">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c1" id="ixv-145">Class A common stock, $0.00001 par value per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c1" id="ixv-146">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c1"
      decimals="INF"
      id="ixv-147"
      unitRef="shares">1400000</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c1"
      decimals="INF"
      id="ixv-148"
      unitRef="usdPershares">7.13</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric contextRef="c1" decimals="INF" id="ixv-149" unitRef="usd">9982000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c1" decimals="INF" id="ixv-150" unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c1" decimals="0" id="ixv-151" unitRef="usd">1379</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="c0" decimals="INF" id="ixv-152" unitRef="usd">9982000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="c0" decimals="0" id="ixv-153" unitRef="usd">1379</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="c0" decimals="0" id="ixv-154" unitRef="usd">0</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="c0" decimals="0" id="ixv-155" unitRef="usd">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="c0" decimals="0" id="ixv-156" unitRef="usd">1379</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c1" id="ixv-110">&lt;table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 99%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0px 0pt;"&gt; &lt;div style="margin-bottom: 4pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(1)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0px 5.4pt; text-align: left;"&gt; &lt;div style="margin-bottom: 4pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Pursuant to Rule 416(a) under the Securities Act
of 1933, as amended (the &#x201c;&lt;span style="text-decoration:underline"&gt;Securities Act&lt;/span&gt;&#x201d;), this Registration Statement
shall also cover any additional shares of the Registrant&#x2019;s Class A common
stock, par value $0.00001 per share (&#x201c;&lt;span style="text-decoration:underline"&gt;Common Stock&lt;/span&gt;&#x201d;), that become
issuable by reason of any stock dividend, stock split, recapitalization, or
other similar transaction effected without receipt of consideration that
increases the number of outstanding shares of Common Stock.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table style="font-size: 12pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt;
   &lt;tr style="height: 0px; font-size: 0px;"&gt;&lt;td style="width: 1%;"&gt;&#160;&lt;/td&gt;&lt;td style="width: 99%;"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="vertical-align: top;"&gt;
    &lt;td style="padding: 0px 0pt;"&gt;
     &lt;div style="margin-bottom: 4pt;"&gt;
      &lt;span style="font-size: 10.0pt;"&gt;(2)&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
    &lt;td style="padding: 0px 5.4pt; text-align: left;"&gt;
     &lt;div style="margin-bottom: 4pt;"&gt;
      &lt;span style="font-size: 10.0pt;"&gt;Estimated in accordance with Rule 457(c) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $7.13 per share, which is the average of the high and low prices of Common Stock on April 16, 2026, as reported on the Nasdaq Capital Market.&lt;/span&gt;
     &lt;/div&gt;
    &lt;/td&gt;
   &lt;/tr&gt;
  &lt;/table&gt;</ffd:OfferingNote>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-159">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-160">0001781162</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-161">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-162">N/A</ffd:OffsetTableNa>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
